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More data provide more possibilities. Growing number of genomic data provide new perspec-
tives to understand some complex biological problems. Many algorithms for single-study have
been developed, however, their results are not stable for small sample size or overwhelmed by
study-specific signals. Taking the advantage of high throughput genomic data from multiple
cohorts, in this dissertation, we are able to detect novel fusion transcripts, explore complex
gene regulations and discovery disease subtypes within an integrative analysis framework.
In the first project, we evaluated 15 fusion transcript detection tools for paired-end RNA-
seq data. Though no single method had distinguished performance over the others, several
top tools were selected according to their F-measures. We further developed a fusion meta-
caller algorithm by combining top methods to re-prioritize candidate fusion transcripts. The
results showed that our meta-caller can successfully balance precision and recall compared
to any single fusion detection tool.
In the second project, we extended liquid association to two meta-analytic frameworks
(MetaLA and MetaMLA). Liquid association is the dynamic gene-gene correlation depending
on the expression level of a third gene. Our MetaLA and MetaMLA provided stronger
detection signals and more consistent and stable results compared to single-study analysis.
When applied our method to five Yeast datasets related to environmental changes, genes in
the top triplets were highly enriched in fundamental biological processes corresponding to
environmental changes.
iv
In the third project, we extended the plaid model from single-study analysis to multiple
cohorts for bicluster detection. Our meta-biclustering algorithm can successfully discovery
biclusters with higher Jaccard accuracy toward large noise and small sample size. We also
introduced the concept of gap statistic for pruning parameter estimation. In addition, bi-
clusters detected from five breast cancer mRNA expression cohorts can successfully select
genes highly associated with many breast cancer related pathways and split samples with
significantly different survival behaviors.
In conclusion, we improved the fusion transcripts detection, liquid association analy-
sis and bicluster discovery through integrative-analysis frameworks. These results provided
strong evidence of gene fusion structure variation, three-way gene regulation and disease sub-
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1.0 INTRODUCTION
1.1 HIGH-THROUGHPUT GENOMIC DATA
The concept of central dogma was proposed in molecular biology to explain the flow of genetic
information [Crick, 1958; Crick et al., 1970]. For most creatures, DNA carrying the genetic
information are first transcribed into RNA, and then RNA are translated into proteins to
construct the organism. In order to explore the functional process, especially the disease
mechanism, data from different molecular levels are collected to learn the mechanisms of
regulation, interaction, modification, etc. These multiple types of omics data are listed in
but not limited to Fig. 1.1. At DNA level, single nucleotide polymorphisms (SNPs) data,
gene mutation (insertion, deletion and mutation) and copy number variation (CNV) data
are widely learned. At the epigenetic level, data for DNA methylation, histone modification,
transcription factor (TF) regulation are collected. At RNA level, messenger RNA (mRNA)
and micro-RNA (miRNA) data are analyzed to study alternative splicing, trans-splicing or
other modification mechanisms. At protein level, data for ribosomal RNA (rRNA), post-
translation modification or protein-folding are measured for analysis.
Genome refers to a complete set of DNA within a cell of an organism, and genomics
is the study of genome, including structure, function, evolution, mapping, regulation or
modification of the genes as well as the influence of environmental factors. Thus genomics
offers new opportunities to study many complex diseases and their diagnostic methods.
In order to explore genes in whole-genome scale, many high throughput technologies are
developed and applied in real application. Data generated from different platforms require
specific pre-processing and data mining pipelines. In the following, we will introduce two
main platforms – microarray and next generation sequencing (NGS) technologies, as well as
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their data format and some conventional pre-processing pipelines.
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Figure 1.1: Protein expression in central dogma.
1.1.1 Microarray
A microarray is a 2D chip to assay biological signals by hybridizing a large amount of
biological material to the probes attached to it in parallel. The technology was proposed in
mid 90’s and nowadays has been largely applied to high throughput genomics data analysis:
expression profiling, SNP detection, ChIP on chip, etc. mRNA expression profiling is one
of the microarray applications that can simultaneously monitor the expression levels of tens
of thousands of transcripts with high sensitivity and specificity. These advantages provides
opportunities to study gene association, genes that are differentially expressed between case
and control samples, gene expressions responding to environmental factors or developmental
stage.
A genomic cohort typically consist of attributes of thousands of genes among multiple
samples by combining several microarray experimental data. Take the mRNA expression
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profiling as an example. After pre-processing, it forms a data matrix format where con-
ventionally each row represents a probe (or gene) and each column represents a sample (or
condition). Fig. 1.2 shows the detailed symbol annotation. Mathematically, the data matrix
is defined as Y ∈ Rn×p, where n and p are total number of genes and samples. Element Yij
represents the expression intensity (or log2 intensity) of gene i for sample j.
Figure 1.2: Data Structure for gene expression profile.
Microarray gene expression data matrix usually requires the following pre-processing
steps.
1. Missing value imputation. Influenced by the background noise, signals for low expressed
transcripts are hard to be detected. In this case, probes for some samples will show
out NA values if the signal is lower or noisy to a certain cutoff. Many DNA microarray
imputation methods have been developed and compared comprehensively [Liew et al.,
2011; Moorthy et al., 2014]. In this dissertation, we implemented the simplest k-NN
imputation method, where missing value is imputed by the mean value of its k nearest
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neighbors defined by pairwise gene distance [Troyanskaya et al., 2001; Altman, 1992].
2. Sample normalization. Since different microarrays (for samples or conditions) are mea-
sured given slightly different reagent concentration, their intensity range may differ from
each other. In order to compare the genes among different samples, each sample should
be normalized to the same scale at the very beginning. Based on different normaliza-
tion purposes, many methods have been proposed [Quackenbush, 2002], where quantile
normalization is a widely used one [Amaratunga and Cabrera, 2001].
3. Probes to genes mapping. Probes on gene chips are designed to be oligonucleotides that
can hybridize to mRNA molecules specifically. The probe can thus quantify the mRNA
from which the oligonucleotides sequenced from. In order to study the expression pattern
in gene level (instead of probe level), probes need to be matched to their corresponding
gene annotations. In real microarray probe design, more than one probe may match to
the same gene. In this dissertation, for a given gene, we chose the representative probe
which has the highest interquartile range (IQR) among samples.
4. Gene filtering. In general, filtering out potentially non-significant genes will gain sta-
tistical power [van Iterson et al., 2010; Bourgon et al., 2010]. In order to detect more
significant signals under the same FDR control, we filtered out those non-expressed (low
mean) and non-informative (low variance) genes in the pre-processing step.
Note that, based on different research purposes, the order and methods of these pre-
processing steps need to be adjusted accordingly.
1.1.2 Next generation sequencing
Next generation sequencing (NGS), also known as high-throughput sequencing (HTP) , were
developed in the mid to late 1990s. It is named ‘next-generation’, because NGS is able to
sequence millions of DNA segments in parallel, instead of targeted sequencing on a few DNA
molecules. This technology is also called deep sequencing given the fact that it provides
possibility to sequence the whole transcriptome and genome for a given organism. Based
on different sequencing principles, NGS includes the following technologies or platforms:
Massively Parallel Signature Sequencing (MPSS), Polony Sequencing, 454 pyrosequencing,
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Illumina (Solexa) sequencing, ABI SOLiD sequencing, Ion semiconductor sequencing, DNA
nanoball sequencing, etc.
NGS technology includes but not limited to the following applications:
1. Whole genome sequencing (WGS) or whole exon sequencing (WES) is to sequence the
complete DNA sequence of an organism’s genome in parallel, including chromosomal
DNA, mitochondria DNA and chloroplast DNA (for plant). The advance of WGS ac-
celerates the study of genomic structure variation (deletion, insertion, inversion, tandem
duplication, dispersed duplication, copy-number variation, etc) and single nucleotide
polymorphism (SNP: single nucleotide substitution, insertion and deletion) [Ng and Kirk-
ness, 2010; Choi et al., 2009]. Taking the advantage of WGS technology, genome wide
association study (GWAS) is able to find genetic variations that contribute to or associate
with some complex diseases, such as cancer, asthma and heart disease.
2. RNA sequencing (RNA-seq) is a high-throughput transcriptome sequencing technology to
determine all or part of the messenger RNA (mRNA), small RNA and non-coding RNA in
a given sample. In this technique, RNA molecules are selected by poly-A oligonucleotide,
and then reverse transcribed into DNA molecules for sequencing. RNA-seq technology,
on one hand, can be applied to detect structure variations at the transcriptome level,
for example: fusion transcript detection, alternative splicing, novel isoform detection,
etc [Trapnell et al., 2010; Liu et al., 2016]. On the other hand, RNA-seq data can be
processed to gene expression data that has similar format as microarray data (Fig. 1.2).
Compared to microarray technology, RNA-seq is not limited by probe design, and thus
is able to discover novel transcripts (or isoforms).
3. Whole genome bisulfite sequencing (WGBS) or MethylC-seq is a technique to sequence
bisulfite-treated DNA fragments to determine their methylation patterns. In the library
preparation when given bisulfite treatment, only un-methylated cytosines are converted
into uracils, while methylated cytosines keep unchanged. In the PCR step, uracils are
amplified as thymines. As a result, only methylated cytosines are sequenced as they are,
while un-methylated cytosines turn out to be thymines [Urich et al., 2015]. Cytosine
methylation can significantly modify spatial gene expression and chromatin structure,
and thus associate with many complex diseases. The application of WGBS technique
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provides a strong support to locate and quantify the cytosine methylation patterns.
4. ChIp sequencing (ChIP-seq) is a method to analyze protein interactions with DNA. In
the chromatin immunoprecipitation (ChIP) step, DNA combined with proteins of inter-
est are sonicated into fragments and then immunoprecipitated by the protein-specific
antibody. Then in the sequencing step, selected DNA fragments are sequenced by the
NGS technology pipeline. As a result, only the DNA regions that can specifically bind
to the protein of interest are collected and sequenced. With the help of ChIP-seq tech-
nology, protein binding sites can be mapped precisely and globally, and thus accelerate
the study of protein-DNA interaction [Park, 2009].
5. Hi-C sequencing is a technology to study the chromatin 3D interaction in a high through-
put scale. Chromosome conformation capture (3C) method analyzes the spatial interac-
tions between genomic loci. Improved from 3C method that quantifies the interaction
between two specific fragments, on the contrary, Hi-C method quantifies all the possible
pairwise interaction in the whole chromatin scale. In the Hi-C technique, DNA in the
same crosslinked complex is first digested with a restriction enzyme, marked with a bi-
otinylated nucleotide at the end, and then ligated together to form one chimeric DNA
molecule. After removing biotin from the end of the DNA pieses, those DNA fragments
with internal biotin are selected and sequenced in a high throughput scale. As a result,
spatially interactive DNA pairs are sequenced together. After aligning the reads to ref-
erence genome, the Hi-C sequencing technology is able to quantify spatial connection
between genomic loci in a whole chromatin scale [Belton et al., 2012].
In this dissertation, we majorly focused on analyzing RNA-seq data. Starting from the
raw FASTQ file, it usually requires the following pre-processing steps.
1. Quality control. Quality control is always the very first step to check the sequencing
data quality. Several key points are analyzed to evaluate the quality: per base sequence
quality, per sequence quality scores, per sequence GC content, sequence duplication
levels, overrepresented sequences, etc [Wang et al., 2012a].
2. Data trimming. Based on the sequencing quality, reads are trimmed out majorly by two
criteria. (1) Read quality score. For example, a moving window is applied to check along
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the reads. If the average quality inside a window is smaller than a certain threshold, then
the sequence inside and after this window will be trimmed out, because it’s a general
trend that the sequencing quality drops as the reads extending longer. (2) Adaptor
trimming. If the length of sequencing read is greater than that of DNA fragment, the
reads might include adaptor sequence at the tail part. In order not to influence the
following alignment analysis, reads need to be trimmed by the adaptor region to increase
the alignment rate [Bolger et al., 2014].
3. Sequence alignment. Generally there are three types of alignment. (1) Reference-based
alignment. Given the organism genome reference, reads are mapped to the position
with the highest matching score. Specifically for RNA-seq data, because of alternative
splicing, one transcript can consist of more than one non-consecutive regions (exons).
In this case, one read might be split into several short pieces for alignment [Kim et al.,
2013]. (2) De novo assembly. Without any prior knowledge, reads with overlapped
regions are formed into contigs, and then contigs will be assembled into scaffols [Baker,
2012]. Compared to reference-based method, de novo assembly requires large computing,
but on the other hand, it can potentially discover novel transcripts. (3) Mix of the two
methods. In order to take the advantage of both pipelines, reads can be first aligned to
the organism reference. And then those un-mapped read can build up their own library
by the de novo assembly. Hybridize of the two pipelines can both increase the alignment
efficiency and accuracy, as well as discover novel transcripts.
4. FPKM value or read count value calculation. Structure variations at the transcript level
can be detected by raw or aligned RNA-seq data directly. However, for gene expression
profiling, further processing are needed to calculate the gene abundance. FPKM, defined
as fragments per kilo-base per million reads, is normalized by gene length and total
number of reads to describe gene expression intensity. Since its data structure is the
same as microarray’s (Fig. 1.2), many conventional pipeline for microarray analysis
(DE, clustering, classification, etc.) can also be applied into FPKM value. Besides,
read count for each gene region can be calculated. Instead of continuous expression
intensity, element Yij in the data matrix represents the number of reads aligned to gene
i in sample j. In this scenario, algorithms designed for continuous value or based on
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normal assumption are no longer suitable for this new data structure. Many new models
(for example, poisson or negative binomial models) are developed to simulate the data
and for differential expression analysis [Robinson et al., 2010; Love et al., 2014].
1.1.3 Large public database and data depositories
Take the advantage of public genomic databases and data repositories, researchers are able
to search and collect multiple types of omic data contributed by different cohorts. Here we
listed several public database used in this dissertation:
• The National Center for Biotechnology Information (NCBI)
https://www.ncbi.nlm.nih.gov/
• Gene Expression Omnibus (GEO)
https://www.ncbi.nlm.nih.gov/geo/
• The Cancer Genome Atlas (TCGA)
https://cancergenome.nih.gov/
University of Pittsburgh mirror: Pittsburgh Genome Resource Repository (PGRR)
http://pgrr.pitt.edu/
Broad institute collection: Firebrowse
http://firebrowse.org/
1.2 INTEGRATIVE ANALYSIS FOR GENOMIC DATA
Motivated by the availability of large public database, the genomic integrative analysis aims
to statistically combine multiple types of omics data from different cohorts. Specifically, as
illustrated in Fig. 1.3 horizontal meta-analysis refers to the integration of the same type of
omics data (for example, gene expression data) among multiple cohorts. Vertical integrative
analysis, on the other hand, refers to the study of multiple types of omics data within the
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Figure 1.3: Illustration of integrative analysis for different types of omcis data among multiple
cohorts.
Compared to single-study analysis, integrative analysis has but not limited to the fol-
lowing advantages:
• Results from single study is lack of power, especially when the sample size is small.
However, integrative analysis is able to gain power by enlarging the sample size.
• Combining normalized single-study directly (mega-analysis) will introduce strong batch
effect due to the sequencing pipeline, platform and sample bias. Integrative analysis, in
contrast, can conquer this problem and take the advantage from each single study.
• Signals detected from single study might be study-specific, and thus can not be general-
izable to other cohorts. On the contrary, many integrative analysis methods are able to
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detect both consistent and study-specific signals among multiple studies.
There are typically two categories of information integration: combining effect sizes and
combining p-values.
When combining effect sizes, fixed effects and random effects models are widely used.
On the one hand, fixed effect model is defined as Tk = θ + k with k ∼ N (0, σ2k), where Tk
is the observed effect size of study k, θ is the mean effect size, and k is the sampling error
for study k. On the other hand, random effects model is defined as Tk = θ + k + ζk with
k ∼ N (0, σ2k) and ζk ∼ N (0, τ 2), where ζk is an additional term for underlying population
variance.
When combining p-values to calculate a meta p-value, many evidence aggregation and
order-statistic methods have been developed. For example, Fisher’s method, Stouffer’s
method, Logit method, minP, maxP, rth ordered p-value, etc [Chang et al., 2013]. In or-
der to differentiate study-specific and consistent signals, methods like adaptively weighted
Fisher’s method are developed to assign binary weight to each study [Li et al., 2011a].
However, many complex machine learning methods cannot be easily extended into meta-
analysis by simply combining effect sizes or p-values, and thus many new meta-analytic
models are required to fill in the blank. For example, Kang et al. [2012] developed a meta
quality control pipeline to quantify multiple data qualities by six data-data similarity mea-
surements. Shen and Tseng [2010] investigated two approaches of meta-analysis for pathway
enrichment (MAPE) by combining statistical significance across studies at the gene level
(MAPE G) or at the pathway level (MAPE P). Huo et al. [2016] propose a meta sparse
k-means algorithm for disease subtype detection and matching among multiple cohorts.
In this dissertation, we include one pipeline for the integration of fusion transcript de-
tection tools, and two horizontal meta-analysis pipelines for liquid association and bicluster
discovery. We will give a brief review of each concept in the following introduction sections.
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1.3 BRIEF REVIEW OF FUSION TRANSCRIPT
Fusion transcript is a chimeric RNA encoded by a fusion gene at the DNA level or formed
by trans-splicing of two different genes at the RNA level. At the DNA level, fusion gene
is defined as a chimeric gene that formed from two previously separate genes. It can occur
as a result of chromosomal translocation, deletion or inversion. At the transcript level, for
trans-splicing, exons from two different primary RNA transcripts are fused together by RNA
processing.
1.3.1 Classification of fusion transcript
In general, fusion transcripts in prostate cancer can be classified into three categories on the
basis of the protein structure of the head gene and the tail gene in the fusion transcripts
[Luo et al., 2015]:
1. Chimera protein forming fusion transcript. Translation of fusion protein occurs at the
ATG start codon of the head gene, and connect it in frame with the C-terminus of the
tail gene.
2. Independent wild type tail gene fusion transcript. Fusion point occurs at the 5’ untrans-
lated region of the mRNA such that both ribosomal binding site and ATG start codon
are preserved. The consequence of such fusion is independent translation of the tail gene
in the transcript, while the expression of the tail gene is driven by head gene promoter.
Head gene may or may not express a truncated protein.
3. Non-fusion forming fusion transcript. The ATG translation start codon and the ribosome
binding site of the tail gene are deleted, while the head gene has C-terminus truncation
or has lost the open reading frame all together. In rare occasion, a wild type head gene
is preserved in non-fusion forming fusion transcript.
1.3.2 Application of fusion transcript
The discovery of fusion transcripts has many clinical applications, especially in tumorigenesis
and cancer progression. Fusion transcripts may create a chimeric protein with a new or
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altered activity. Alternatively, it can contribute to the over-expression of a seemingly normal-
expressed gene, or down-regulation of a tumor suppressor gene.
Here we summarize two applications of fusion transcript.
First of all, fusion transcript can behave as biomarker to predict cancer clinical status
such as, relapse versus non-relapse, or fast relapse versus non-fast relapse. For example, Yu
et al. [2014] detected 8 novel fusion transcripts from prostate cancer. Among 179 samples
from UPMC cohort, samples with and without fusion detected showed out significantly
different survival trend by Kaplan-Meier analysis. Two conventional indicators – Gleason
score and Nomogram – were traditionally used for the prediction of prostate cancer status.
However, the performance will be significantly improved by adding the existence status of
fusion transcripts as prediction attributes. As another example, Yan et al. [2015] proposed
that the ratio of large size copy number variations was able to predict the prostate cancer
relapse or non-relapse status. With the addition of fusion transcripts, the prediction results
were improved significantly.
Secondly, fusion transcripts (or fusion gene) play roles as therapeutics target for some
diseases. For example, Cools et al. [2003] found that fusion FIP1L1-PDGFRα might be
the cause of hypereosinophilic syndrome by forming a novel fusion tyrosine kinase via an
interstitial chromosomal deletion process. The study showed that FIP1L1-PDGERα is the
target of imatinib and the deletion of genetic material may result in gain-of-function fusion
protein. Take the research by Chen et al. [2017] as another example. MAN2A1-FER is a
fusion gene between the mannosidase domain of MAN2A1 and tyrosine kinase domain of
FER. Expression of MAN2A1-FER protein generated dramatic increase of growth and inva-
sion of cancers in vitro and in vivo, while removal of the fusion through knockout generated
significant lower level of growth and metastasis.
1.3.3 Detection or validation methods of fusion transcript
Because of the wide application of fusion transcripts, it is important to test the fusion events
for a given sample and to discover novel fusion transcripts from new samples. Generally,
there are two experimental validation methods.
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• RT-PCR + Sanger sequencing. These techniques can quantify the DNA molecules and
get the exact sequence for a given primer-designed region. As shown in Fig. 1.4, if the
sequenced region consists of the sequences from two separate genes, then it is a strong
proof that these two genes are fused together.
Figure 1.4: Illustration of fusion transcripts validated by RT-PCR + Sanger sequence
method.
• Fluorescence in situ hybridization (FISH). As illustrate in Fig. 1.5, FISH is able to specif-
ically insert fluorescence markers to two candidate genes. Then under the microscope, if
fluorescence spots from two genes pair together, it will strongly support the fusion event.
However, the methods introduced above have their limitations. Both methods can only
validate the existence of known (or suspicious) fusions, but are not able to discover novel
fusions in a whole-genome scale. For example, RT-PCR + Sanger sequencing can only target
on a certain region. It requires the prior knowledge of two candidate genes in order to design
their primer sequences. But this technique fails to test all the possible gene combinations in
a high throughput scale. Similar for FISH method, scientists are only able to insert markers
to candiate gene pairs for testing. Nevertheless, it is impossible to mark all the genes to test
all the potential pairwise combinations.
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Figure 1.5: Illustration of fusion transcripts validated by fluorescence in situ hybridization
(FISH) method.
Figure 1.6: Illustration of fusion transcripts detected by RNA-seq.
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Those limitations motivate the idea of introducing high throughput sequencing method
into fusion transcripts detection. WGS and RNA-seq are two techniques to discover fusion
events at DNA and RNA level, respectively. Take the RNA-seq detecting fusion transcripts
as an example. Fig. 1.6 shows an illustration drawn by SOAPfuse software [Jia et al., 2013]
where reads from RNA-seq support the fusion of two genes marked by blue and orange colors.
Generally, there are two kinds of supporting reads. On one hand, spanning read is defined
as the paired-end read where one end is aligned to blue gene and the other end is aligned
to orange gene. Split read, on the other hand, exactly covers the break point and splits into
two parts that can be aligned to two genes separately. Similar to RNA-seq, WGS detects
fusion genes at the DNA level. In addition, it is able to locate the break point inside the
intron region by the support of split reads.
Many fusion transcripts detection tools have been developed for paired-end RNA-seq
data. In the first project of this dissertation, we comprehensively evaluated 15 pipelines in
terms of precision, recall, accuracy, number of supporting reads and computing cost. We
then proposed a meta-caller to combine several top tools to improve the balance between
precision and recall rate.
1.4 COMPLEX GENE REGULATION PATTERNS
1.4.1 Gene regulation and co-expression
Gene expression is the process of synthesizing multiple functional gene products. For ex-
ample, coding genes generate proteins, which are the most commonly used functional units
to construct the organism. As illustrated in Fig. 1.1, information flows from gene to RNA
and then to protein by the following process: transcription, RNA splicing, translation, and
post-translational modification of a protein. Alternatively, non-protein coding genes produce
functional RNA, such as transfer RNA (tRNA) or small nuclear RNA (snRNA).
Regulation of gene expression refers to the mechanisms that are used to control the
amount and timing of functional gene products (protein or RNA). These mechanisms include
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the regulation at each step of information flow: transcriptional initiation, RNA processing
and post-translational modification of a protein. Gene regulation is the basis for cellular
proliferation, differentiation, morphogenesis, apoptosis, and adaptation to various external
signals, such as environmental changes, new food sources and other stimuli.
Exploring the gene regulation pattern plays an important role to understand complex
biological process, and thus reveals the mechanisms of pathogenesis and tumorigenesis. The
study of gene regulation can trace back to 1961 where Jacques Monod identified lac operon, in
which the expression of some lactose-involved enzymes in E. coli is triggered by the presence
of lactose and absence of glucose. As for now, taking the advantage of high throughput
technology, gene regulation can be learnt in a whole-genome scale. That is to say, instead of
focusing on a few individual genes, scientists are able to study the genome-wide expression
pattern of a sample under certain conditions, such as drug treatment, physical or chemical
stimulus, cell cycle, etc.
The relationships of gene expression can be represented in the form of gene network,
where each node represents a gene and each edge indicates the interaction [D’haeseleer et al.,
2000; De Jong, 2002]. In this scenario, network graph can be divided into two subtypes. Gene
regulatory network can be translated into a directed graph, where an arrow from molecule
A to B represents the regulation of A to B. Alternatively, Gene co-expression network is an
undirected graph, where an undirected edge connecting two genes means the co-expression
relationship between them.
It takes two steps to construct a gene co-expression network. First, gene distances are
calculated between all pairwise genes. The co-expression relationship can be measured by
Pearson’s correlation coefficient, Mutual Information, Spearman’s rank correlation coefficient
or Euclidean distance. In the second step, genes are connected only if their co-expression
measure is greater than a certain threshold, or the p-value of the measure can reach a defined
significance cutoff. For example, an edge will connect two genes as long as their absolute
value of Pearson’s correlation is greater than 0.7, otherwise no connection.
However, the construction procedure above only considers the pairwise gene association.
As a matter of fact, the actual biological regulation patterns are more complex than this sim-
ple model. Motivated by this limitation, Li [2002] proposed the concept of liquid association
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that will be introduced below.
1.4.2 Liquid association
Liquid association (LA), proposed by Li [2002], is the study of three-way gene regulation. In
contrast to pairwise gene association (solid association), LA measures the dynamic gene-gene
association given a third scouting gene. For example, as illustrated in Fig. 1.7, gene X and
Y are highly positively correlated when the expression level of gene Z is high, while they
are highly negatively correlated when the expression of gene Z is low. This kind of dynamic
pattern, however, cannot be detected by the traditional pairwise association because the
reverse correlations under two conditions may neutralize the overall correlation.
Figure 1.7: Illustration of liquid association between gene X and Y given a third scouting
gene Z.
Take the urea-cycle genes as an example to illustrate liquid association [Li, 2002]. Many
genes involved in urea cycle are predicted to or physically correlate with each other, however
their pairwise Pearson correlations are not significant. Detected by LA method, gene SCH9
behaved as a scouting gene that can regulate many gene pairs correlation. When SCH9
was low, gene pairs (ARG2, ARG1), (ARG2, ARG3), (ARG2, ARG4) and (ARG2, CAR1)
were all positively co-expressed. In contrast, when SCH9 was high, all these four gene pairs
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were negatively or not correlated. As another example, Li et al. [2004] studied the Stanford
cell cycle data and found that the pairwise correlation of gene (GCD11, SUI3), (GCD11,
SUI2), and (SUI2, SUI3) were low. However, scouting genes RPL11B, RPL10, DBP10, IFH1
and DBP10 were detected which can dynamically regulate the association of the above gene
pairs. In conclusion, liquid association is able to quantify three-way gene regulation, and
even predict novel gene regulation or co-expression patterns.
To quantify liquid association, Li [2002]; Li et al. [2004, 2007] estimated the LA score to
be LA(X, Y |Z) = E(XY Z) when standard normalized the data. Ho et al. [2011] improved
the estimation framework by proposing the modified liquid association (MLA) method. In
order to search the gene triplets in whole genome scale, Gunderson and Ho [2014] developed
a fast algorithm to pre-filtered those non-significant triplets to reduce the computing cost.
In the second project of this dissertation, we further extended the algorithm into meta-
analytic framework to take the advantage of multiple cohorts.
1.5 BICLUSTERING OF GENE EXPRESSION DATA
Clustering is an unsupervised machine learning method to cluster similar objects into the
same group. As we introduced in the above section, the gene expression matrix has the
format as it is shown in Fig. 1.2, where row represents gene and column represents sample.
In general, there are two clustering directions for gene expression data. For one direction in
Fig. 1.8A, genes with similar expression patterns are clustered together. In this case, genes
within one cluster are expected to be enriched in some similar biological pathways. For the
other direction in Fig. 1.8B, similar samples with the same disease subtypes are grouped
together. In order to cluster genes or samples, many machine learning clustering methods
have been developed, such as k-means [Hartigan and Wong, 1979], hierarchical clustering
[Eisen et al., 1998] and model based approaches [McLachlan et al., 2002].
However, there are several limitations for one-way clustering in terms of genes and sam-
ples selection. On one hand, a disease subtype is only correlated with the expressions of a
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Figure 1.8: Illustration of Clustering and Biclustering on gene expression data.
subset of genes, instead of whole list of genes. So it will weaken the signal if samples are
clustered using all the gene attributes. On the other hand, some genes can regulate multiple
disease subtypes while the others may only correspond to one or no disease subtype.
These limitations motivate the idea of biclustering. That is, the algorithm aims to detect
a subset of genes and a subset of samples simultaneously. As illustrated in Fig. 1.8C, a sub-
matrix from the original gene expression matrix is selected. Not limited to one bicluster,
usually multiple biclusters with different expression patterns can be detected (Fig. 1.8D).
1.5.1 Types of biclusters
Mathematically, we defined Yij to be the expression intensity of gene i in sample j. Based
on different expression pattern models, Freitas et al. [2012] categorized the biclusters into 5
types.
1. Bicluster with constant expression values. Mathematically, Yij = µ, where µ is the
constant mean expression value.
2. Bicluster with constant values on rows or columns. For bicluster with constant values on
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rows, it can be written as Yij = µ+αi or Yij = c×αi, where αi is the row effect for gene
i, and c is a constant parameter. Similarly, bicluster with constant values on columns
can be written as Yij = µ+ βj or Yij = c× βj, where βj is the columns effect for sample
j.
3. Bicluster with coherent values. To combine the previous equations, bicluster element can
be defined as Yij = µ+ αi + βj, or Yij = c× αi × βj.
4. Bicluster with linear coherent values. Bicluster can be obtained by the linear format as
Yij = c× αi + βj.
5. Bicluster with coherent evolution. That is , bicluster rows (or columns) include a linear
order across a subset of columns (or rows).
1.5.2 Biclustering algorithms
The concept of biclustering was first introduced by Hartigan [1972] and then applied into
gene expression data by Cheng and Church [2000]. Many biclustering algorithms have been
developed to detect different bicluster patterns [Ruffalo et al., 2011; Eren et al., 2013; Madeira
and Oliveira, 2004]. Here we summarize several algorithms that have been widely used.
• Cheng and Church. Cheng and Church [2000] first applied biclustering into gene expres-
sion matrix. Defined aij as the data element for row i and column j, I and J are row and
column sets of the bicluster. This algorithm aims to detect biclusters that can minimize
the mean squared residual (MSR). Mathematically, MSR = 1|I||J |
∑
i∈I,j∈J(aij − aiJ −
aIj + aIJ)













• Conserved gene expression motifs (xMOTIFs). Murali and Kasif [2003] aims to detect
biclusters with consistent row expression. Each row of the data matrix is first discretized
into several status. Then a seed is defined as a randomly selected column, and a dis-
criminating set is defined as randomly selected set of columns. xMOTIFs tries to detect
rows that have same states over the columns of the seed and the discriminating set.
• Correlated pattern biclusters (CPB). Bozdag˘ et al. [2009] proposed this algorithm to
detect biclsuters with high row-wise correlation measured by Pearson correlation coeffi-
cient. As an initiation, CPB randomly selects a row and some random columns. Then
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it iteratively adds rows that have high correlation with the seed row, and columns that
have smaller root mean squared error (RMSE).
• Plaid model. Lazzeroni and Owen [2002] assumes the data matrix expression value is
the superposition of multiple layers (biclsuters). Mathematically, the expression element
can be expressed as Yij = θ0 +
∑K
k=1 θkρikκjk + ij = (µ0 + αi0 + βj0) +
∑K
k=1(µk + αik +
βjk)ρikκjk + ij, where θ is the overall expression value that can be defined as the main
(µ), gene (α) and sample (β) effect, ρik and κjk are gene i and sample j indicator for
layer k with 1 meaning selected and zero otherwise. More details will be introduced in
the third project.
• Bayesian biclustering (BBC). This algorithm extends the plaid model into a hierarchical
Bayesian analysis by Gibbs sampling [Gu and Liu, 2008]. However, it only allows the
biclusters overlapping in either gene or sample directions. Many other Bayesian methods
have been proposed for different models [Caldas and Kaski, 2008; Zhang, 2010].
• Spectral biclustering. In a cancer context, checkerboard patterns are defined as genes
that are markedly up- or down-regulated in patients with particular types of tumors.
Kluger et al. [2003] proposed the spectral algorithm to detect this kind of checkerboard
pattern by eigenvectors corresponding to characteristic expression patterns across genes
or conditions. As a result, only biclusters with low variance are detected when applying
this method.
• Factor analysis for bicluster acquisition (FABIA). This model assumes the expression





i + γ = ΛZ + γ, where each bicluster is the outer product of
two sparse vectors: row vector λ and column vector z. Some other methods using factor
analysis were also developed [Martella et al., 2008].
1.5.3 Evaluation of biclusters
Detected biclusters can be evaluated in two scenarios. On one hand, for synthetic data with
the underlying truth, many measurements have been developed to quantify the similarity
between two clusters [Horta and Campello, 2014]. Except for those complex evaluation
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methods, here we introduced several direct and widely used ones.
Fig. 1.9 shows the overlapping between predicted and true biclusters. True positives
(TPs) are defined as the overlapped elements between the two clusters, false positives (FPs)
are the elements only detected by predicted bicluster but not by true biclsuters, (FNs)
are the elements only in true but not in predicted bicluster, and true negatives (TNs) are














Figure 1.9: Overlapping between predicted bicluster and true bicluster elements.
On the other hand, for real data biclustering without known truth, detected genes and
samples are checked respectively to evaluate the performance.
Selected bicluster genes are usually checked by their enrichment of some collected gene
sets. A biological pathway describes a series of molecules that are related to a certain biolog-
ical functions. Genes are conventionally grouped by their correlated biological pathways or
physical interactions. Thus, bicluster genes are expected to significantly enriched with some
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of these gene sets so that they can be evaluated as functionally related gene sets. Fisher’s
exact test is used to test the association between biclsuter gene set and some conventionally
defined gene pathways [Upton, 1992].
Biclustring is expected to split the samples into different disease subtypes or treatment
conditions. With the patients’ prior knowledge, association between sample splitting (sam-
ples selected or not selected by the biclsuter) and their clinical information. Alternatively,
Kaplan-Meier analysis can be used to evaluate the sample splitting in terms of survival
behaviors.
Motivated by the high throughput genomic data and the integrative analysis, in the
third project, we extended the plaid model for single-study analysis into a meta-analytic
framework. In the third project, we will introduce more details of the plaid model and how
can its objective function be improved for multiple-cohorts biclustering.
1.6 MAIN CONTRIBUTIONS AND SPECIFIC AIMS
In this dissertation, we are taking the advantage of multiple high-throughput genomics data
to extend the fusion transcript detection, liquid association and biclustering into integrative
analysis framework. Here are the main contributions of this dissertation,
• We evaluated 15 fusion transcript detection tools in paired-end RNA-seq data, and de-
veloped a meta-caller to re-prioritize the fusion transcript candidates by combining the
results from top performing tools.
• We explored more robust gene-triplet liquid association among multiple transcriptomic
cohorts.
• We extended the plaid model into a meta-analysis framework to detect biclusters from
multiple cohorts with consistent gene selection.
Below we outline the three projects in this dissertation.
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1.6.1 Aim 1. Comprehensive evaluation of fusion transcript detection algo-
rithms and a meta-caller to combine top performing methods in paired-
end RNA-seq data
Background: Fusion transcripts are formed by either fusion genes (DNA level) or trans-
splicing events (RNA level). They have been recognized as a promising tool for diagnosing,
subtyping and treating cancers. RNA-seq has become a precise and efficient standard for
genome-wide screening of such aberration events. Many fusion transcript detection algo-
rithms have been developed for paired-end RNA-seq data but their performance has not
been comprehensively evaluated to guide practitioners. In this paper, we evaluated fifteen
popular algorithms by their precision and recall trade-off, accuracy of supporting reads, and
computational cost. We further combine top-performing methods for improved ensemble
detection.
Results: Fifteen fusion transcript detection tools were compared using three synthetic data
sets under different coverage, read length, insert size and background noise, and three real
datasets with selected experimental validations. No single method dominantly performed
the best but SOAPfuse generally performed well, followed by FusionCatcher and JAFFA.
We further demonstrated the potential of a meta-caller algorithm by combining top perform-
ing methods to re-prioritize candidate fusion transcripts with high confidence that can be
followed by experimental validation.
Conclusions: Our result provides insightful recommendations when applying individual
tool or combining top performers to identify fusion transcript candidates.
1.6.2 Aim 2. Meta-analytic framework for liquid association
Motivation: Although coexpression analysis via pair-wise expression correlation is popu-
larly used to elucidate gene-gene interactions at the whole-genome scale, many complicated
multi-gene regulations require more advanced detection methods. Liquid association is a
powerful tool to detect the dynamic correlation of two gene variables depending on the ex-
pression level of a third variable ( LA scouting gene). Liquid association detection from
single transcriptomic study, however, is often unstable and not generalizable due to cohort
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bias, biological variation, and limited sample size. With the rapid development of microarray
and NGS technology, liquid association analysis combining multiple gene expression studies
can provide more accurate and stable results.
Results: In this paper, we proposed two meta-analytic approaches for liquid association
analysis (MetaLA and MetaMLA) to combine multiple transcriptomic studies. To compen-
sate demanding computing, we also proposed a two-step fast screening algorithm for more
efficient genome-wide screening: bootstrap filtering and sign filtering. We applied the meth-
ods to five Saccharomyces cerevisiae data sets related to environmental changes. The fast
screening algorithm reduced 98% of running time. Compared with single study analysis,
MetaLA and MetaMLA provided stronger detection signal and more consistent and stable
results. The top triplets are highly enriched in fundamental biological processes related to
environmental changes. Our method can help biologists understand underlying regulatory
mechanisms under different environmental exposure or disease states.
Availability: : A MetaLA R package, data and code for this paper are available at
http://tsenglab.biostat.pitt.edu/software.htm.
1.6.3 Aim 3: Meta-analytic plaid model for detecting biclusters when combin-
ing multiple transcriptomic studies
Motivation: When analyzing transcriptomic data, clustering genes can identify gene mod-
ules with highly correlated patterns across all samples, where the co-expressed genes are
likely co-regulated or share common biological functions. To account for patient hetero-
geneity, biclustering methods can detect gene modules correlated in a subset of samples.
With increasing number of gene expression profiles accumulated in public databases, com-
bining multiple transcriptomic studies by meta-analytic approaches not only improves statis-
tical power but also provides more consistent results. This motivates the meta-biclustering
method proposed in this paper.
Results: We developed a biclustering plaid model towards meta-analytic framework for
integrating multiple transcriptomic studies. Gap statistic was introduced to determine tun-
ing parameters in the algorithm. Using extensive simulations, we showed that the new
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meta-biclustering method generated more accurate and robust clustering results. Bicluster
genes selected by training cohorts are generalizable to testing cohorts. The method was fur-
ther applied to five breast cancer expression profiles. Identified bicluster genes were highly
enriched in previously characterized breast cancer related pathways. The corresponding bi-
cluster samples were significantly associated with ER status and survival behavior. These
expression signatures form basis to characterize disease subtypes for possible personalized
medicine.
Availability: : A MetaBiclust R package, data and code for this paper are available at
http://tsenglab.biostat.pitt.edu/software.htm and GitHub.
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2.0 AIM 1. COMPREHENSIVE EVALUATION OF FUSION TRANSCRIPT 
DETECTION ALGORITHMS AND A META-CALLER TO COMBINE TOP 
PERFORMING METHODS IN PAIRED-END RNA-SEQ DATA
This is a pre-copyedited, author-produced version of an article accepted for publication in 
Nucleic Acid Research following peer review. The version of record [Liu et al., 2016] is 
available online at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797269/.
2.1 INTRODUCTION
Fusion gene is a result of chromosomal insertion, deletion, translocation or inversion that joins 
two otherwise separated genes. Fusion genes are often oncogenes that play an important role 
in the development of many cancers. Trans-splicing is an event that two different primary 
RNA transcripts are ligated together. Both fusion genes (DNA level) and trans-splicing 
events (RNA level) can form fusion transcripts. These events usually come from different 
types of aberrations in post-transcription and chromosomal rearrangements: large segment 
deletion (e.g. the well-known fusion TMPRSS2-ERG in prostate cancer [Tomlins et al., 
2005]), chromosome translocation (e.g. the well-known fusion BCR-ABL1 in chronic myeloid 
leukemia [Barnes and Melo, 2002] and EML4-ALK in non-small-cell lung cancer [Soda et al., 
2007]), trans-splicing [Gingeras, 2009] or readthrough (two adjacent genes) [Kaye, 2009]. 
To date, many fusion transcripts have been found and collected in public databases. For 
example, there are 10,890 fusions in COSMIC (release 72) [Forbes et al., 2015], 1,374 fusion 
sequences found in human tumors (involving 431 different genes) in TICdb (release 3.3) [Novo 
et al., 2007], 2,327 gene fusions in the Mitelman database (updated on Feb 2015) [Mitelman
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et al., 2015], and 29,159 chimeric transcripts in ChiTaRS (version 2.1) [Frenkel-Morgenstern
et al., 2013, 2015]. Some databases (such as COSMIC, TICdb and ChiTaRS) collected
fusion gene sequences and some (e.g. COSMIC and ChiTaRS) offered further summaries of
the original tissue types.
The advances in Massively Parallel Sequencing (MPS) have enabled sequencing of hun-
dreds of millions of short reads and have been routinely applied to genomic and transcrip-
tomic studies. The per-base sequencing resolution has provided a precise and efficient stan-
dard for fusion transcript detection, especially using paired-end RNA-Seq platforms [Maher
et al., 2009]. For example, Berger et al. detected and verified 11 fusion transcripts in
melanoma samples, and also identified 12 novel chimeric readthrough transcripts [Berger
et al., 2010]. McPherson et al. verified 45 out of 268 detected fusion transcripts in ovarian
and sarcoma samples [McPherson et al., 2011a]. Kangaspeska et al. detected and verified
13 fusion transcripts in breast cancer cell lines [Kangaspeska et al., 2012]. Sakarya et al.
detected and verified another 25 fusion transcripts in breast cancer cell lines [Sakarya et al.,
2012]. Furthermore, Chen et al. proposed a method, BreakTrans, which combined RNA-Seq
and whole genome sequencing data of breast cancer samples to detect fusion transcripts
[Chen et al., 2013]. Since 2010, many computational tools have been developed for detecting
fusion transcripts using RNA-Seq data (see a comprehensive list of 23 methods in Table
A.1). Wang et al. [Wang et al., 2013], Carrara et al. [Carrara et al., 2013] and Beccuti et al.
[Beccuti et al., 2013] provided insightful reviews of these pipelines. Beccuti et al. developed
an R package Chimera that can organize and analyze fusion transcripts detected by multiple
tools [Beccuti et al., 2014].
Fig. 2.1A shows two common types of fusion transcripts: intact exon (IE) type and
broken exon (BE) type. For IE-type, the rearrangements generally occur in intronic regions
and the transcript break point locates exactly at the boundary of the exon, while for BE-
type the break point can be in the middle of an exon. To detect these fusion transcripts,
paired-end reads are powerful to generate spanning reads, with one read aligned to gene A
and the other paired read aligned to gene B (see left plot of Fig. 2.1B). Alternatively, a read
can be partially aligned to gene A and partially to gene B (see right plot of Fig. 2.1B). This
kind of supporting reads are called split reads and are useful to define the exact transcript
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break point of the fusion transcript. The length of the partial alignment to each fused gene
is called anchor length. We usually require a minimal threshold of anchor length (e.g. 10
bp) otherwise false positives will increase due to ambiguous multiple alignments of the short
partial reads.
Despite rapid development of many computational tools, their respective performance
has rarely been evaluated systematically. Carrara et al. compared eight fusion transcript
detection tools mostly published in or before 2011 [Carrara et al., 2013]. The evaluation used
a small scale of simulated datasets and two real datasets, and the comparison considered
sensitivity without proper false positive control, causing inconsistent conclusions and failing
to provide a useful application guideline. Developers of recently proposed tools, such as
SOAPfuse [Jia et al., 2013], FusionQ [Liu et al., 2013] and JAFFA [Davidson et al., 2015],
provided similar small-scale comparative study but the evaluations are all minimal and not
conclusive. Many obstacles have hindered the generation of a comprehensive and insightful
evaluation, including numerous intermediate steps and parameters that may impact the
result in each pipeline, difficulties of proper installation of many tools, frequent updates of
software versions and lack of convincing benchmarks for evaluation.
In this paper, we aim to perform a comprehensive evaluation of up to 15 fusion transcript
detection tools (Table A.2), to provide a conclusive application guideline and to explore an
improved ensemble detection algorithm by combining multiple top-performing methods. We
applied three synthetic data sets under different coverages, read lengths and background
noises (Table A.3, A.4, A.5 and A.6) with 150 designed underlying true fusions (80 IE-
type and 70 BE-type) and also evaluated the tools in three real datasets with experimental
validations (Table A.7). We evaluated using three criteria: precision-recall plot (for both
synthetic and real data), accuracy of supporting reads (for synthetic data only) and com-
putation cost (for one synthetic and one real dataset). The results will provide researchers
and practitioners with insightful recommendations when using these pipelines. Among the
15 evaluated tools, no single method dominantly performed the best for all data. We further
explored an ensemble (or meta-caller) algorithm by combining three top-performing algo-
rithms (SOAPfuse, FusionCatcher and JAFFA) to improve recall rate while maintain high
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Figure 2.1: Figures to explain terminology. (A)IE-type and BE-type fusion transcripts; (B)
spanning read, split read and anchor length; (C) short and long insert size of DNA fragment
for sequencing.
precision. Result of the meta-caller was desirable to detect more candidate fusion transcripts
with high confidence.
R package FusionMetaCaller is available on our website http://tsenglab.biostat.pitt.edu/
software.htm.
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2.2 MATERIALS AND METHODS
2.2.1 Overview of fusion transcript detection tools
To the best of our knowledge, we summarized 23 state-of-the-art fusion transcript detec-
tion tools in Table A.1, among which, 15 tools were examined in this study (Table A.2):
MapSplice [Wang et al., 2010], ShortFuse [Kinsella et al., 2011], FusionHunter [Li et al.,
2011b], FusionMap [Ge et al., 2011], deFuse [McPherson et al., 2011a], chimerascan [Iyer
et al., 2011], FusionCatcher [Edgren et al., 2011; Nicorici et al., 2014], TopHat-Fusion [Kim
and Salzberg, 2011], BreakFusion [Chen et al., 2012], EricScript [Benelli et al., 2012], SOAP-
fuse [Jia et al., 2013], FusionQ [Liu et al., 2013] , SnowShoes-FTD [Asmann et al., 2011],
PRADA [Torres-Garc´ıa et al., 2014] and JAFFA [Davidson et al., 2015]. These detection
tools differ in a variety of aspects, including read alignment methods [Li and Homer, 2010],
criterion for determining fusions, advanced filtering criteria and final output information.
In read alignment, for example, many tools (such as TopHat-Fusion, chimerascan, deFuse,
FusionCatcher, FusionQ and SnowShoes-FTD) align all reads to the reference sequence using
Bowtie [Langmead et al., 2009] or Bowtie2 [Langmead and Salzberg, 2012]. Other alignment
tools such as EricScript, BreakFusion and PRADA use BWA [Li and Durbin, 2009], SOAP-
fuse uses SOAP2 [Li et al., 2009] and FusionMap has its own alignment algorithm. SOAP-
fuse, chimerascan, deFuse, EricScript, FusionCatcher, BreakFusion, PRADA and JAFFA use
more than one alignment tool (combine with BLAT [Kent, 2012], STAR [Dobin et al., 2013]
or BLAST [Camacho et al., 2009]) to increase the accuracy of alignment and fusion break
point detection. In addition, some detection tools include assembly tools to construct new
references with the alignment results. FusionQ, BreakFusion and FusionCatcher use cuﬄinks
[Trapnell et al., 2010], TIGRA-SV [Mills et al., 2011] and velvet [Zerbino and Birney, 2008]
respectively to improve the true positive rate with the expense of more computing times
and memories. In our implementation, we adopted the most recent versions in May 2015
and used the default alignment settings in each of the 15 pipelines to have fair comparison
(except that we fine-tuned the parameters of TopHat-Fusion which will be discussed later).
A second essential factor that affects fusion detection performance is the filtering criteria
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since candidate fusion transcripts from preliminary alignment can easily generate thousands
of false positives. Most pipelines require minimal threshold of spanning and split reads (see
column 4 in Table A.2) that support the finding of a fusion transcript. Many also require a
minimal thresholds of anchor length filtering (i.e. the minimum base pairs on either fused
genes) for split reads (column 2 in Table A.2). In this paper, we set minimum supporting
spanning and split reads to be 3 and 1 and minimum anchor length to be 10 bp whenever
the pipeline allows the setting to be specified. Many tools also provide advanced filtering
for read-through transcripts, PCR artifacts, gene homologs (e.g. homologous or repetitive
regions, or pseudo genes) and checking against existing fusion transcript databases. Table
A.2 provides all details of the parameters or availability of filtering criteria in each pipeline.
In the final column, we also commented on any installation or application complexity of the
tools.
Different fusion detection tools contain tremendously different sets of parameters and
definitions. For example, FusionCatcher contains more than 40 parameters, including trim-
ming options, search fusion gene options, filtering options and so on. On the other hand,
BreakFusion has only several parameters that can be changed. In our experience, parameter
settings can greatly influence the detection performance. For example, when we applied the
default setting to TopHat-Fusion, no fusion transcript was detected in the Melanoma datasets
(see real data section). But the performance improved significantly when we changed several
key parameters (see Table A.8). How to set the best parameter setting for each tool and
each dataset is obviously beyond the scope of this paper. As a result, we decided to only
fix several key parameters whenever possible, otherwise we followed the default setting in
each tool. In addition to minimum spanning reads (≥ 3), minimum split reads (≥ 1) and
anchor length (≥ 10) described above, we allowed 1 mismatch per 25 bp (i.e. 2, 3 and 4
mismatches for 50, 75 and 100 bp reads, respectively) (see Table A.9 for parameter setting
details for each tool). For the insert size parameters (mean and standard deviation) in the
tools, we provided the truth for synthetic data and performed estimation using BWA [Li
and Durbin, 2009] for real data. Among the 15 pipelines, we only fine-tuned TopHat-Fusion
since TopHat tools are very popular in the field but TopHat-Fusion performed poorly in real
data under the default setting (Table A.8). Whenever a tool cannot run in a specific dataset,
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we attempted to debug and/or contact the authors to solve the problem. Table A.10 lists all
remaining failure runs after all the efforts that lead to several incomplete results in Table 2.1.
Specifically, FusionHunter failed for all synthetic data and ShortFuse also failed for most of
them, so we could only effectively compare 13 tools in synthetic data.
Table 2.1: F-measure for three representative synthetic datasets and three real dataset.
Type-1A: read 100 bp under 100X coverage for type-1A synthetic data; Type-1B: read 100
bp under 100X coverage for type-1B synthetic data; Type-3B: read 50 bp type-3B synthetic
data (mean F-measure of the five control samples); Breast cancer: pool 4 samples of breast
cancer datasets; Melanoma: pool 6 samples of melanoma datasets; Prostate cancer: pool 5
samples of prostate cancer datasets.












SOAPfuse 0.882 0.883 0.850 0.421 0.169 0.148 2.615 0.738 3.353
FusionCatcher 0.777 0.791 0.750 0.405 0.300 0.209 2.318 0.914 3.232
JAFFA 0.693 0.672 0.702 0.543 0.267 0.006 2.067 0.816 2.883
EricScript 0.779 0.804 0.752 0.291 0.074 0.006 2.335 0.371 2.706
chimerascan 0.737 0.706 0.689 0.267 0.049 0.010 2.132 0.326 2.458
PRADA 0.545 0.543 0.540 0.469 0.334 0 1.628 0.803 2.431
deFuse 0.630 0.854 0.561 0.235 0.095 - 2.045 0.330 2.375
FusionMap 0.684 0.711 0.606 0.075 0.041 0.004 2.001 0.120 2.121
TopHat-Fusion 0.488 0.557 0.539 0.300 0.200 0 1.584 0.500 2.084
MapSplice 0.488 0.500 0.504 0.400 0.182 0 1.492 0.582 2.074
BreakFusion 0.707 0.569 0.454 0.016 0.004 0 1.730 0.020 1.750
SnowShoes-FTD 0.039 0.039 0.039 0.639 0.500 0.435 0.117 1.574 1.691
FusionQ 0.651 0.479 0.349 0.017 - - 1.479 0.017 1.496
FusionHunter - - - 0.520 0.421 - - 0.941 0.941
ShortFuse - - - 0.543 0.291 - - 0.834 0.834
2.2.2 Description of evaluated datasets
2.2.2.1 Real data The real datasets in this study consisted of 4 breast cancer cell lines
(BT-474, SK-BR-3, KPL-4 and MCF-7) [Edgren et al., 2011], 6 melanoma samples (M980409,
M010403, M000216, M000921, M990802 and 501Mel) [Berger et al., 2010] and 5 prostate
cancer specimen (171T, 165T, 158T, 49T and 159T) [Yu et al., 2014]. There were a total of
27 experimentally verified fusion events for breast cancer cell lines, 11 for melanoma samples
and 12 for prostate cancer specimen that will serve as the underlying truth for evaluation.
Table A.7 describes the details of the three real datasets.
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2.2.2.2 Three synthetic data sets We first created two types of fusion transcripts for
synthetic data in this study (as shown in Fig. 2.1A): (1) a fusion transcript with the associ-
ated fusion breakpoint formed by two intact exons (IE) from two different genes (called an
IE-type fusion transcript); and (2) a fusion transcript with the left and/or right sides around
the associated breakpoint being a broken exon(s) (BE) (called a BE-type fusion transcript).
Here we simulated paired-end RNA-Seq data with synthetic fusion transcript events using
the simulator in EricScript [Benelli et al., 2012]. Type-1A synthetic data were generated from
the 5’ and 3’ end of the chimerical transcripts using wgsim (https://github.com/lh3/wgsim)
with insert size 500± 50 bp. We generated datasets with five different coverages of 5X, 20X,
50X, 100X and 200X, each with three read lengths 50, 75 and 100 bp. The dataset with the
largest coverage, i.e. 200X, was first simulated and then other datasets with smaller cover-
ages (5X, 20X, 50X and 100X) were sequentially generated by subsampling (Table A.4). For
each synthetic dataset, we simulated 80 IE-type fusion transcripts and 70 BE-type fusion
transcripts (Table A.3). As a result, we generated 15 datasets in type-1A synthetic data and
each dataset contained 150 true fusion transcripts.
In real experiments, the insert size (i.e. the DNA fragment size between paired-end
adapters) can be pre-specified and designed by control reagent and fragmentation time in
the protocol (TruSeq RNA Sample Preparation v2 Guide). Fig. 2.1C illustrates the short
and long insert size DNA fragments with paired-end reads aligned to them. Left figure shows
short insert size where paired-end reads cover most of the DNA fragment or even overlap
in the middle; right figure shows long insert size where distance between the paired-ends
is much larger. In the literature, reads with longer insert size help to detect long-range
isoforms in paired-end RNA-seq and reads with shorter insert size and deeper coverage can
fill in the gaps (An introduction to next-generation sequencing technology) [Katz et al.,
2010]. Similarly, to detect fusion transcripts, library with longer insert size provides more
spanning reads. Furthermore, some algorithms use the insert size of supporting reads as an
criterion to filter out potential false positives. For example, FusionMap includes abnormal
insert fragment size filtering, and this step can greatly influence the result [Ge et al., 2011].
In this paper, using BWA alignment tool [Li and Durbin, 2009], we estimated the insert sizes
of three paired-end real data to be around 180± 80 bp, 400± 150 bp and 150± 40 bp in the
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breast cancer, melanoma and prostate cancer data, respectively (Table A.7). As a result, we
generated a second type of synthetic data (type-1B) using the same procedure as type-1A
synthetic data except for smaller insert size at 250± 50 bp.
In type-2 data, we further used a control dataset from a normal lung tissue sample
(SRR349695) [Zhang et al., 2012], in which we assumed no fusion transcript existed (though
fusions may also exist in normal tissues). We randomly chose 2 million reads with read length
100 bp from this control sample and then trimmed the reads at 3’ end to 75 bp and 50 bp
to form the other two read length sets. This kind of dataset served as a negative control
to benchmark whether the tools generate false positives from no-signal data. In type-3A
data, we generated synthetic datasets with insert size 164± 48 bp (which was the insert size
estimated from type-2 data) under 100X with length 50, 75 and 100 bp. Each dataset also
contained the same 80 IE-type and 70 BE-type fusion transcripts. In type-3B data, we mixed
type-2 and type-3A data together to test the background influence to the fusion detection
tools. To increase the reliability of the comparison, we also used four additional normal
samples – parathyroid (SRR479053) [Haglund et al., 2012], skeletal myocyte (SRR1693845)
[Va¨remo et al., 2015], bladder (SRR400342) and T cell (SRR1909130) [Cao et al., 2015]
samples – to generate type-2 data and combined with type-3A data (with their own insert
size respectively) to generate type-3B synthetic data. Table A.5 and A.6 show details of type-
2 and type-3 synthetic data. All these synthetic data sets contain the same 150 designed
fusions (Table A.3).
2.2.2.3 Validation data set To evaluate the performance of meta-caller (will be intro-
duced in Results section), an experimentally synthesized fusion sequencing dataset was used
to serve as validation data (SRP043081, SRR1659964) [Tembe et al., 2014]. This paired-end
dataset contains nine designed fusion transcripts as the underlying truth.
2.2.3 Performance benchmarks and evaluation criteria
We benchmarked different fusion detection tools using three evaluation criteria below. The
first precision-recall plot and F-measure served as the primary benchmark for detection ac-
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curacy performance which can be used for both synthetic and real data. The second criterion
of supporting read identification was used only in synthetic data and mainly benchmarked
the alignment efficiency. Finally, computational efficiency was evaluated to assess feasibility
of the tools for big data sets with deep sequencing and/or large sample size.
2.2.3.1 Precision-recall plot In synthetic data, exactly 150 true fusion transcripts were
known (Table A.3) to benchmark the performance of different methods. However, in real
data, only a small set of validated fusion transcripts was available. Since a detection tool only
reports the findings of possible fusion transcripts and the total positives were not entirely
known in real data, popular receiver operating characteristic (ROC) curves for classification
evaluation were not applicable.
Instead, the scenario was similar to information retrieval problems [Salton and McGill,
1986], in which the precision-recall curve was a better benchmark of the performance. Sup-
pose TP, FP and FN are the true positives, false positives and false negatives of the findings
from a detection tool. The precision rate (a.k.a. positive predictive value) is defined as
TP/(TP+FP) that reflects the accuracy among the claimed fusion transcripts. High preci-
sion, however, does not guarantee good performance since one method can conservatively
call only few fusion transcripts with high accuracy. As a result, we need the method to also
have high recall rate (a.k.a sensitivity) defined as TP/(TP+FN). The precision-recall plot
(precision on the y-axis and recall on the x-axis) seeks a method to have high precision and
high recall near the (precision, recall)=(1,1) area. For a given result from a detection tool,
we ranked the detected fusion transcripts according to the number of identified supporting
reads (sum of spanning and split reads) and derived a precision-recall curve under different
top numbers of detected fusions’ thresholds. The classical F-measure simultaneously consid-
ers the effect of the precision and recall rates by taking the harmonic means of the precision
and recall rates (i.e., F-measure = 2 × precision × recall / (precision + recall)), and was
used to benchmark different methods.
2.2.3.2 Identification of supporting reads in synthetic data Identification of sup-
porting spanning and split reads is a reflection of alignment accuracy and is the basis of
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fusion transcript detection. Following the convention in the previous sub-section, we focused
on the 150 true fusion transcripts in synthetic data and calculated the number of detected
supporting reads in each true fusion transcript. In the distribution plot, a point (u, v) means
that u out of the 150 true fusion transcripts have at least v detected supporting reads us-
ing the given detection pipeline. To better quantify and visualize similarity of identified
supporting reads from different tools and the underlying true supporting reads, we applied
multi-dimensional scaling plots where the dissimilarity measure between any two supporting
read lists is defined as the sum squared differences of supporting reads (sum of spanning and
split reads) of the 150 true fusion transcripts. The MDS plot helps quantify clusters of tools
with similar alignment and supporting read detection performance.
2.2.3.3 Computational cost Recent reports have shown that sequencing depth is an
important factor in detecting cancer related fusion transcripts due to tumor cell heterogeneity
(i.e. a fusion transcript may only exist in partial tumor cells) [Yu et al., 2014; Luo et al.,
2015]. In high coverage data, many pipelines demanding large memory and computing may
become infeasible. We used four CPU cores for each fusion transcript detection tool on the
type-1A synthetic data with read length 100 bp under coverage 50X, 100X and 200X to
benchmark computing time for small datasets. Furthermore, to test the tool capacity to
handle large datasets, we used 8 cores on the prostate cancer 171T dataset and its one-half,
one-fourth and one-eighth subsamples (Table A.11) and attempted to characterize whether
the computing time was increased at linear, sub-linear or super-linear rate. The machine is
Linux-based, with AMD sixteen-core CPU 2.3GHz.
2.3 RESULTS
2.3.1 Evaluation in synthetic data
2.3.1.1 Type-1A and 1B Synthetic Data In type-1A synthetic data evaluation, all
15 fusion detection methods (Table A.2) were applied to 15 datasets of five coverages (5X,
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20X, 50X, 100X, and 200X) and three read lengths (50, 75 and 100 bp). FusionHunter failed
for all synthetic data and ShortFuse failed for most of them (see Table A.10, failed trials
were excluded from further analysis). Fig. 2.2A indicates the numbers of true positives
(bars shown on the y-axis, solid bars for IE-type and slashed bars for BE-type) and total
numbers of fusion detection (the numbers marked on top of the bars) by each tool for read
length 100 bp results (results for 50 bp and 75 bp are shown in Fig. A.1) for type-1A
synthetic data. Fig. A.2 shows the 15 F-measures (as well as precisions and recalls) for
five coverages and three read lengths in type-1A synthetic data (results of 100X and 100
bp read length are marked by red cross). For a representative demonstration, Fig. 2.2D
shows the precision-recall curves in the 100X and 100 bp read length setting. In precision-
recall plots, tools that generate higher recall rate under the same precision rate demonstrate
better performance. In Fig. 2.2A, increasing coverages improved detection sensitivities for
almost all tools. Most tools were equally powerful in detecting both IE and BE types of
fusion transcripts except that PRADA and SnowShoes-FTD could not detect any BE-type
fusions. When comparing impact of read length (Fig. 2.2A and Fig. A.1), increased read
length under fixed coverage did not improve the detection sensitivity. This was probably
because under fixed coverage, increasing read length decreased the total number of reads
in the dataset (Table A.4). This finding was consistent with a previous report in bisulfite
sequencing [Krueger et al., 2012]. By balancing precision and recall in Fig. 2.2D and Table
A.12, we can visually identify SOAPfuse, FusionCatcher and EricScript to achieve high recall
rate (up to 92.7% for SOAPfuse, 72.0% for FusionCatcher and 69.3% for EricScript) while
maintaining high precision (≈ 80% - 90%). JAFFA and PRADA appeared to be conservative
but accurate tools that can achieve only 58.7% and 38.0% recall rate but maintained high
precision rate (84.6% for JAFFA and 96.6% for PRADA). The complementary performance
of these top performing tools motivated the development of the ensemble method to combine
these methods in a later section.
Similar to type-1A evaluation, Fig. 2.2B and 2.2E show information of detected true
positives and precision-recall curves at read length 100 bp for type-1B synthetic data (insert
size 250 ± 50 bp )(Fig. A.3 shows results for 50 and 75 bp; Fig. A.4 shows F-measure of
all 15 settings; Table A.13 shows F-measure of 100bp dataset). In these shorter insert size
38
data, tools were more sensitive to sequencing coverage. For example, BreakFusion detected
(33-3)/3=10-fold more true fusions when increasing the coverage from 5X to 20X. Similarly,
JAFFA and PRADA identified 4.8-fold and 4.6-fold more true fusions. Even SOAPfuse and
FusionCatcher, which were not sensitive to low coverages at 500 bp insert size datasets,
detected 65 and 40 more true positives (TPs) from 5X to 20X.
2.3.1.2 Type-2 and type-3 synthetic data with background noise In most cancer
applications, tumor cells are often contaminated by adjacent normal cells to cause hetero-
geneity. To investigate the influence of such background noise, we first randomly gener-
ated type-2 synthetic data from normal lung tissues (SRR349695) [Zhang et al., 2012] (or
parathyroid (SRR479053) [Haglund et al., 2012], skeletal myocyte (SRR1693845) [Va¨remo
et al., 2015], bladder (SRR400342) and T cell (SRR1909130) [Cao et al., 2015] sample) that
were assumed to contain no designed fusion event. We then generated synthetic data con-
taining 150 true fusion transcripts in type-3A and then mixed type-2 and type-3A data to
form type-3B synthetic data. Since the insert size for type-2 data is small (164± 48 bp for
lung sample), we mainly focused on the results with read length 50 bp. Fig. 2.2C shows the
result of type-2 (BG), type-3A (100X) and type-3B (100X+BG) lung tissue synthetic data
at read length 50 bp (Fig. A.5 similarly shows results for 75 and 100 bp; Fig. A.6 shows
F-measure of three read lengths; Fig. A.7 shows detection results for the other four tissues
on 50 bp read length and Fig. A.8 shows their corresponding F-measures; Table A.14 shows
F-measure of 100bp dataset and Table A.15 shows the correlation between five tissues by
the F-measure of the 15 tools). From type-2 dataset (BG) in Fig. 2.2C, all tools detected
almost none fusion transcripts as they were supposed to, except that FusionQ detected 28
false positives (FPs). Comparing results of type-3A and type-3B, BreakFusion increased
the total number of detections significantly while the TPs remained almost the same. Fu-
sionQ was also sensitive to background influence, whose TPs increased significantly (from
9 to 37) with the sacrifice of increasing the total detections (from 10 to 74). DeFuse was
also influenced by background noise with less TPs detected (decreased from 70 to 43). On
the other hand, methods such as SOAPfuse, FusionCatcher, JAFFA, EricScript, chimeras-
can, PRADA, FusionMap, TopHat-Fusion and MapSplice were almost not influenced by the
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background noises. Fig. 2.2F shows the precision-recall curves for type-3B synthetic data.
Overall, FusionCatcher and EricScript performed the best to maintain high precision and
stayed robust from background noise (Fig. 2.2C and 2.2F).
2.3.1.3 Alignment efficiency and detection similarity across pipelines To com-
pare the alignment efficiency of each tool with the underlying truth, we analyzed the number
of detected supporting reads for the 150 designed fusion transcripts (as well as 80 IE-type
only and 70 BE-type only) via type-1A synthetic data. In Fig. 2.3A-C, for each tool, the
y-axis of the distribution plot represents the number of detected designed fusion transcripts
based on consideration of the fusion transcripts with the number of total identified support-
ing reads (sum of spanning and split reads) being larger than the specified values set on the
x-axis. The black line represents the results of the ground truth and other color lines repre-
sent different tool results. The closer the lines of the tools to the ground truth, the better
the ability of correctly aligning the supporting reads. Fig. 2.3A, 2.3B and 2.3C considered
the total 150 designed fusions, 80 IE-type and 70 BE-type fusions, respectively. These fig-
ures show the results for type-1A synthetic datasets with 100X and 100 bp read length (the
results with read lengths 50 and 75 bp under 100X coverage are shown in Fig. A.9). In
Fig. 2.3A-C, we note that except for SOAPfuse, all the other tools missed some of the true
fusions (e.g. all other tools missed 50-100 fusions in Fig. 2.3A). Of them, FusionCatcher
(solid orange), EricScript (solid bright pink), JAFFA (solid bright green), TopHat-Fusion
(dash dark green), FusionQ (dash red), deFuse (solid dark purple) and MapSplice (dash
orange) seemed to have preferential alignment efficiency on a subset (50-80) of true fusion
transcripts and can detect high supporting reads for partial of them (flat decreasing curves
in Fig. 2.3A-C). Other callers tended to have sudden drops at 50-100 supporting reads,
showing overall under-performance of alignment. SOAPfuse’s superior alignment capability
was consistent with the finding in a previous report [Ruffalo et al., 2011]. It required higher
computational cost (see Computational Efficiency section) but it can also include modest
number of false positive reads (number of supporting reads greater than the truth on the
high end). This may explain SOAPfuse’s high recall rate (≈ 90%) and high precision rate
(≈ 80− 90%) in Fig. 2.2D.
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Figure 2.2: Fusion transcript detection results for synthetic datasets with 100 bp read lengths.
(A)-(C): The y-axis bars show the number of true detected positives, among them IE-type
and BE-type fusions are shown in solid and slashed rectangles. The total number of fusion
detections are shown on the top of the bars. (A) Result for type-1A synthetic data (100 bp
read length), (B) result for type-1B synthetic data (100 bp read length) and (C) result for
type-2, type-3A and type-3B synthetic data (lung sample 50 bp read length). (D) Precision-
recall plot for type-1A synthetic data (100 bp read length & 100X). (E) Precision-recall
plot for type-1B synthetic data (100 bp read length & 100X). (F) Precision-recall plot for
Type-3B synthetic data (lung sample 50 bp read length & 100X).
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In Fig. 2.3D-F, we further examined the alignment similarity of the tools by multi-
dimensional scaling (MDS) plots (tools closer to each other had more similar fusion sup-
porting reads detection) in 100 bp read length. The result showed a close-to-the-truth
performance of SOAPfuse, FusionCatcher and EricScript. FusionQ appeared to have very
different alignment result from all other methods although its overall cumulative distribution
did not much differ. The differential pattern of supporting reads detection provided the basis
and rationale to combine multiple callers for improving fusion detection (discussed later).
The results for 50 and 75 bp are shown in Fig. A.10.
2.3.1.4 Balance between precision and recall curve Precision and recall rates assess
the tradeoff between true positives and false positives, measuring the tools’ ability to detect
more TPs with the cost of less FPs. A high recall rate indicates that the algorithm could
detect most of the 150 true fusion transcripts while a high precision rate indicates that most
of the fusion transcripts detected are true positives. In our analysis, we used precision-recall
curves and calculated F-measure that balances between precision and recall (see Methods
section) to benchmark the performance of different tools. The first three columns in Table 2.1
shows the F-measures of Type-1A, 1B and 3B results of different methods. As shown in Fig.
2.2D and Table A.12, the highest F-measure with 100 bp read lengths under 100X coverage in
type 1A was SOAPfuse (92.7% recall rate, 84.2% precision and 0.882 F-measure), followed by
EricScript (F=0.779), FusionCatcher (F=0.777), chimerascan (F=0.737) and BreakFusion
(F=0.707). In type-3B data with background noise, SOAPfuse performed the best, followed
by EricScript, FusionCatcher and JAFFA (Fig. 2.2F and Table A.14). Of special note was
JAFFA and PRADA that maintained high precision rate while only had a comparatively
low recall rate. Such complementary calling properties implied the possibility of combining
FusionCatcher and SOAPfuse, as well as other top performing tools, for further improvement.
2.3.2 Evaluation in real datasets
In the three real datasets, we had 27, 11 and 12 wet-lab validated fusion transcripts but the
full true fusion transcripts were not entirely known. As a result, we drew similar bar plots in
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Figure 2.3: Illustration of alignment performance and similarity across tools for type-1A
synthetic data with 100 bp read length & 100X. (A)-(C): Number of true positives (y-axis)
with detected supporting reads greater than the threshold on the x-axis. (D)-(F): Multi-
dimensional scaling (MDS) plots to demonstrate pairwise similarity of detection results from
15 tools and the underlying truth. (A) and (D): Results for all 150 true fusion transcripts.
(B) and (E): Results for only IE-type fusion transcripts. (C) and (F): Results for only
BE-type fusion transcripts.
Fig. 2.4A-C and used precision-recall plots and F-measure to benchmark the performance
of the tools (Fig. 2.4D-F, Table A.16 A.17 and A.18). For example, in Fig. 2.4A SOAPfuse
identified 35 candidate fusion transcripts in the BT-474 breast cancer cell line, among which
9 cases were validated. In total, SOAPfuse detected 68 fusion candidates across all four
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breast cancer samples, of which 20 were validated (precision = 20/68 = 29.4% and recall
= 20/27 = 74.1%). On the contrary, in prostate cancer example in Fig. 2.4C, EricScript
detects 3809 fusion candidates, of which 11 were validated (precision=11/3809=0.3% and
recall=11/12=91.7%). By comparing F-measure that balancing between precision and recall,
we found that performance of methods varied greatly in different real datasets. Based on
Table 2.1, SnowShoes-FTD, FusionHunter and FusionCatcher are better performers in real
data. In these real data, several tools could not complete running in partial datasets. We had
made our best effort to debug the pipelines, contacted authors and recorded all unfinished
tasks in Table A.10 after all possible effort. Such cumbersome debugging processes are often
encountered when using these pipelines.
2.3.3 Computational efficiency
Since fusion detection involves analysis of large sequencing datasets and complex analysis
pipeline, computational efficiency is an important benchmark, especially for projects involv-
ing deep sequencing and large sample size, an expected trend in the field. Fig. 2.5A shows the
computation time (log-scale on the y-axis) of small datasets using synthetic data with read
length 100 bp and coverage 50X, 100X and 200X. FusionMap appeared to be the fastest
algorithm, followed by similar speed of EricScript, JAFFA, SnowShoes-FTD, MapSplice,
PRADA and TopHat-Fusion. SOAPfuse had good performance in alignment accuracy and
precision-recall evaluation in synthetic data and real data but it apparently required much
more computational resources. Each fusion detection pipelines had its own time-consuming
steps based on its work-flow and tools involved [Kim and Salzberg, 2011]. We used the com-
puting time at 200X and linearly projected to 1/2 and 1/4 computing time for 100X and 50X
with the dashed lines. The result showed that computing time increased in a ‘sub-linear’
pattern for most methods in these datasets (i.e. doubling coverage took less than double
computing time). This was reasonable because large percentage of the computing was spent
on preliminary processing, library preparation and some post-processing steps for such small
data sets. For example, after aligning the reads into BAM file, BreakFusion consists of five
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Figure 2.4: Fusion transcript detection results for three real datasets. Figures are similar to
Figure 2. (A) and (D): Breast cancer dataset; (B) and (E) Melanoma dataset; (C) and (F):
Prostate cancer dataset.
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mate chimeric scores and annotate-and-filter [Chen et al., 2012]. We further tested another
large dataset of prostate cancer sample 171T (118,742,381 reads with 100 bp read length)
in Fig. 2.5B using the entire, 1/2, 1/4 and 1/8 randomly subsampled sequences (Table
A.11). SOAPfuse remained computational costly while JAFFA, deFuse and MapSplice ap-
peared to surpass computational needs of SOAPfuse. DeFuse even failed to complete for
the entire sequencing dataset (did not stop after 16 days). FusionMap, FusionHunter and
SnowShoes-FTD were the most computationally efficient methods. PRADA and deFuse re-
quired super-linear computing time for large datasets (i.e. doubling coverage required more
than double of computing time). Practitioners should pay extra attention to plan enough
computing power for these pipelines when running projects with deep sequencing and large
sample size.
2.3.4 An ensemble algorithm by combining multiple top-performing fusion de-
tection tools
Table 2.1 shows the F-measures of each detection method applied to each synthetic and
real dataset. By ranking the sum of F-measures over three synthetic datasets and three
real datasets, several methods such as SOAPfuse and FusionCatcher consistently performed
well in most datasets but no method was always the top-performer. Strikingly, EricScript,
chimerascan, deFuse and FusionMap performed well in synthetic data (sum of F-measures =
2.335, 2.132, 2.045 and 2.001) but performed poorly in real data (sum of F-measures=0.371,
0.326, 0.330 and 0.120). On the other hand, PRADA, SnowShoes-FTD, FusionHunter and
ShortFuse performed well in real data (sum of F-measures=0.803, 1.574, 0.941 and 0.834)
but performed poorly or failed to run in synthetic data (sum of F-measures=1.628, 0.117,
failed and failed). Such a discrepancy may reflect the fact that the simulation model may be
overly simplified. The three real datasets also shows some heterogeneity. Particularly, many
methods could not run or almost detected nothing for the largest prostate cancer dataset
because of the large size of the data and less validated fusion transcripts. Due to the limited
availability of real data sets with enough amount of validations, we believe that the three
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Figure 2.5: Computational cost comparison. The bar plots (y-axis) show the log-scaled com-
putational time (min). Dashed lines project from the largest dataset with linear computing
time decrease by coverage and can be used to determine linear, super-linear (bars for smaller
coverages fall below the line) or sub-linear (bars for smaller coverages exceed the line) com-
puting load. (A) Evaluation using type-1A synthetic data for read length 100 bp at 50X,
100X and 200X. (B) Evaluation using prostate cancer 171T sample.
their real data. As a result, we recommend users to apply SOAPfuse, FusionCatcher and
JAFFA in order based on the sum of rank of the F-measures from Table 2.1.
In Fig. 2.2, Table A.12, A.13 and A.14, we have observed that SOAPfuse can achieve
above 90% recall rate while FusionCatcher and JAFFA can reach high precision but low
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recall rate. This created a possibility of combining results of these top three pipelines to
improve detection performance provided that fusions detected by FusionCatcher were not all
detected by SOAPfuse. In other words, top performing methods likely had complementary
advantages to accurately detect different types of fusion events. To test this hypothesis,
we combined the three top-performing methods (SOAPfuse, FusionCatcher and JAFFA)
to construct a meta-caller. First of all, we selected fusion events detected by at least two
out of the three methods (Step 1 of Fig. 2.6). We next ranked the detected fusion events
from each method by the number of supporting reads, where larger number of supporting
reads obtained larger rank (Step 2 of Fig. 2.6). Rank sums of the selected fusion events
were calculated (where missing values of the ranks were ignored if the fusion event was not
detected by one of the methods) and the fusion events were re-prioritized accordingly. To test
validity of the new meta-caller, Fig. 2.7 shows the precision-recall performance of the three
top-performing methods as well as the meta-caller (dash black) in different datasets: Fig.
2.7A-C for type 1A, 1B and 3B (lung sample) synthetic data with 100X coverage and read
length 100, 100 and 50 bp respectively (Fig. A.11 shows the meta-caller performance of the
other read lengths for synthetic dataset); Fig. 2.7D-F for pooled breast cancer, melanoma
and prostate cancer real data. In all situations, the meta-caller performed better or at least
equal to the best of the three top-performers. We have also tried to combine top 6 performer
(ranked by Table 2.1, containing SOAPfuse, FusionCatcher, JAFFA, EricScript, chimerascan
and PRADA) and re-ranked the fusion transcripts that detected by at least 3 tools. The
precision and recall curve of the top 6 performer was shown in Fig. A.12 and its performance
is slightly better than top-3 performer, but it takes larger computing efforts.
Admittedly, it’s overfitting to use our synthetic and real data to validate the performance
of meta-caller since the tools are evaluated and ranked from these datasets. So we used a
new dataset sequenced from an experimentally-synthesized fusion transcripts library (nine
designed underlying truth) [Tembe et al., 2014] as the validation data to evaluate the meta-
caller performance. Table A.19 showed the performance summary of each tool. We also
implemented top-3 (Fig. 2.8) and top-6 (Fig. A.13) meta-callers to combine the results from
single tools and the performance still kept on top of single methods (except for equal or
slightly worse than FusionCatcher). This provides a strong evidence to the hypothesis that
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Step	  1:	  Keep	  the	  fusion	  transcripts	  
detected	  by	  at	  least	  2	  tools	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Tool	  1	   Tool	  2	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  3	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  4	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  1	   23	   100	   20	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  2	   66	   130	   -­‐	   34	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  3	   17	   -­‐	   -­‐	   -­‐	  
Fusion	  4	   4	   -­‐	   -­‐	   7	  
…	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   1	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  4	   1	   0	   0	   1	   2	   3	  
…	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  2:	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  each	  tool	  (small	  
to	  large)	  ,	  calculate	  the	  sum	  rank	  and	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  it	  from	  large	  to	  small	  
\suppor-ng	  
reads\	  
Tool	  1	   Tool	  2	   Tool	  3	   Tool	  4	  
Fusion	  1	   23	   100	   20	   22	  
Fusion	  2	   66	   130	   -­‐	   34	  
Fusion	  4	   4	   -­‐	   -­‐	   7	  
…	  
Figure 2.6: Illustration of the meta-caller workflow.
meta-caller improves detection result by combing multiple top-performing tools.
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Figure 2.7: Precision-recall curves of top 3 performing tools and meta-caller. (A)-(C): Type-
1A, type-1B and type-3B (lung sample) synthetic data with 100X coverage and 100, 100 and
50 bp read length respectively. (D)-(F): Three real datasets: breast cancer, melanoma and
prostate cancer.
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Figure 2.8: Precision-recall curves of top-3 performing tools and meta-caller (with majority
vote=2) on validation data.
2.4 DISCUSSION AND CONCLUSION
In this paper, we performed a large-scale comparative study by applying 15 fusion transcript
detection pipelines to three synthetic datasets and three real paired-end RNA-seq studies
on breast cancer cell lines, melanoma samples and prostate cancer specimen. We used
precision-recall plots and the associated F-measures to serve as the primary performance
benchmark for both synthetic and real data (Fig. 2.2D-F, Fig. 2.4D-F and Table 2.1). In
the synthetic data, the underlying truths are known so we further investigated the identified
supporting reads of true fusions from each pipeline as the secondary benchmark to quantify
alignment performance (Fig. 2.3). To evaluate computational cost of each tool for large
sequencing projects, we evaluated running time as the third benchmark (Fig. 2.5). Finally,
we developed a meta-caller algorithm to combine three top-performing methods (SOAPfuse,
FusionCatcher and JAFFA) determined by F-measure (Fig. 2.6). The meta-caller was
evaluated in the three synthetic and real datasets as well as an independent experimental
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data set. The result provided a proof-of-concept justification that the meta-caller almost
always performed better or at least equal to the best performer in each synthetic or real
data scenario and should be recommended in daily applications (Fig. 2.7 and Fig. 2.8).
Fusion detection pipelines often include multiple complicated tools using different pro-
gramming languages (e.g. Perl) and can be easily impacted by local machine setting and
software versions. Unlike platform independent programming languages such as Java and
R, fusion detection pipelines often require extensive script checking and debugging when the
code is transported to a new machine or even rerun on the same machine after an extensive
time period with possible software upgrades. In this paper, we have made our best effort to
generate comparable evaluations by specifying versions of each tool, key parameters expected
to impact the calling discrepancy (e.g. allowed alignment mismatches, minimal supporting
split and spanning reads, minimal anchor lengths and etc.) and keep default settings when-
ever possible. When the tools failed to run after extensive effort, we have contacted the
authors to improve but failures still remained in multiple situations (Table 2.1 and A.10).
Such hurdles are probably still expected in a near foreseeable future and next-generation
sequencing forums, such as SEQanswers, can often provide great help.
We summarize key conclusions from the comprehensive comparative study below.
1. No tool performed dominantly best in all synthetic and real datasets. SOAPfuse per-
formed consistently among the best and followed by FusionCatcher, JAFFA and PRADA
in both synthetic and real datasets. EricScript and chimerascan performed well in syn-
thetic data but poor in the three real datasets we evaluated. The performance of each
tool appeared to be data-dependent and not always consistent between synthetic and
real data.
2. SOAPfuse, FusionCatcher and EricScript overall had the best alignment performance in
the synthetic data evaluation.
3. SOAPfuse was one of the most computationally demanding tool. FusionCatcher and
JAFFA had median computation load. All of the three methods required super-linear
computing in deep-sequenced samples and computing resources should be planned ahead
for large projects.
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4. The meta-caller combining SOAPfuse, FusionCatcher and JAFFA generated better pre-
cision and recall performance than any single tool. Whenever possible, it is recommended
to apply all three pipelines and combine the results in applications.
There are several limitations to our study design. First of all, the evaluation is limited
(or potentially can be biased) by the simulation models, the three available data sets and
the corresponding experimentally validated fusions. We particularly observed that several
tools performed well in synthetic data but poorly in real data or vice versa. Due to limited
number of datasets, we decided to aggregate performance benchmark of all results equally in
Table 2.1. Collecting more real datasets and/or developing more realistic simulation models
for a more conclusive evaluation is a future goal.
Secondly, demonstration of the meta-caller performance (Fig. 2.7, 2.8, A.11, A.12 and
A.13) serves as a proof-of-concept, with only one independent data validation. If more real
datasets and experimentally validated fusions become available in the future, systematic
cross-validation assessment should be performed to evaluate the meta-caller. The increased
information may further inspire new meta-caller methods.
Conclusions from this paper can provide guidelines or foster future research initiatives for
different audience. Although no tool dominantly performed the best, for data analysts and
practitioners the comparative study can guide to avoid using ineffective tools and recommend
to select the top few best pipelines. Our proposed meta-caller framework allows users to
effectively combine results of multiple top performers. For developers of existing tools, our
evaluation can identify the subset of fusions with low detection accuracy in their pipelines
and seek improvement. When a new fusion detection pipeline is developed in the future, our
study will provide an open-source evaluation framework to benchmark the new method. For
the large bioinformatics community, development of a high-performing (accurate and fast)
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3.0 AIM 2. META-ANALYTIC FRAMEWORK FOR LIQUID ASSOCIATION
This is a pre-copyedited, author-produced version of an article accepted for publication in
Bioinformatics (Oxford, England) following peer review. The version of record [Wang et al.,
2017] is available online at https://www.ncbi.nlm.nih.gov/pubmed/28334340.
3.1 INTRODUCTION
Gene co-expression analysis is vastly applied to study pairwise gene synchronization to eluci-
date potential gene regulatory mechanisms. For example, an unweighted gene co-expression
network can be constructed from a transcriptomic study given a co-expression measure (e.g.
Pearson correlation) and an edge cut-off (e.g. two nodes are connected if absolute correla-
tion ≥ 0.6 and disconnected if < 0.6). In the literature, different measures such as Pearson
correlation, Spearman correlation and mutual information [Butte and Kohane, 2000] have
been used (see Song et al., 2012 for a comparative study). Alternatively, Zhang et al. [2005]
developed a WGCNA framework using cluster analysis to construct gene co-expression mod-
ules and their associated weighted co-expression networks. Network properties and extended
pathway analysis can then be studied to investigate disease related network alterations and
mechanisms.
Although guilt-by-association heuristic assumed in gene co-expression network analysis
is widely used in genomics [Wolfe et al., 2005], many complex regulatory mechanisms in the
system cannot be readily captured by direct association because of multi-way interactions.
The first column in Fig. 3.1A shows an example of liquid association first described in
Li [2002]. Gene YCR005C and YPL262W are overall non-correlated in study GSE11452
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(Spearman correlation = 0.239) but they exhibited high correlation (cor = 0.692) when a
third gene YGR175C is low expressed (expression intensity < −0.424) and a much lower
correlation (cor = -0.790) when expression of gene YGR175C is high (> 0.441). The simple
interaction among the trio is biologically meaningful since the third gene YGR175C may
serve as a surrogate of certain (hidden) cellular state or regulator that controls the presence
and absence of co-regulation between gene YCR005C and YPL262W.
To quantify the conditional association in the triplet genes, Li (2012) proposed a liquid
association (LA) measure to quantify the dynamic correlation of two variables depending on
a third variable [Li, 2002; Li et al., 2004; Ho et al., 2011]. Li [2002] introduced this con-
cept and proposed a computationally efficient three-product-moment measure (see Section
3.2.2). Zhang et al. [2007] adopted a simplified LA score based on z-transformed Pearson
correlation conditional on discretized expression of the third gene. Ho et al. [2011] extended
the trivariate dependency structure into a parametric Gaussian framework (called modified
liquid association; MLA) to develop improved estimation frameworks and statistical test for
the existence of the LA dependence. The computational complexity to screen all possible
triplets is O(n3) and is generally too high for applying LA methods in a genome-wide scale.
Gunderson and Ho [2014] introduced an efficient screening algorithm fastLA for the MLA
method containing two steps: (1) screening the candidate triplets by difference between the
correlations of the LA pair when the scouting gene is high and low; (2) fitting and estimating
the model based on conditional normal distributions. The algorithm greatly improved the
computing efficiency for genome-wide LA analysis.
Liquid association estimated from a single study is often unstable and not generalizable
due to cohort bias, biological variation, and sample size limitation. With rapid accumulation
of transcriptomic studies in the public domain, identifying LA triplets by combining multiple
studies is likely to produce more stable and biologically reproducible results. For example,
Fig. 3.1A shows an example of an LA triplet (gene YCR005C, YPL262W, and YGR175C)
where the liquid association is statistically significant in the first yeast study GSE11452
but the LA association does not hold for the remaining four independent studies. Such an


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.1: The scatter plot of the gene expressions in the high and low bins. (A) is for the
triplet selected by GSE11452 through singleMLA and (B) is for the triplet selected by the
studies GSE11452, Causton, and Gasch through MetaMLA.
hand, the LA triplet (YGR264C, YOR197W, and YDR519W) in Fig. 3.1B is obtained
from the combined meta-analysis of the first three studies. The association is more likely
to validate in the fourth and fifth studies. In this paper, we develop two meta-analytic
frameworks for liquid association to accurately identify LA triplets that are consistent across
multiple studies. The result shows that meta-analytic methods generate more stable LA
triplets that are more reproducible in independent studies. The LA triplets also generate
57
better pathway enrichment results to better understand the biological insight and/or generate
further hypothesis.
3.2 METHODS
3.2.1 Data sets and databases
We used five yeast (Saccharomyces cerevisiae) data sets – Causton [Causton et al., 2001],
Gasch [Gasch et al., 2000], Rosetta [Hughes et al., 2000], GSE60613 [Chasman et al., 2014],
and GSE11452 [Knijnenburg et al., 2009] – to illustrate our meta-analytic methods. In each
study, yeast samples are exposed to a variety of environmental stress and the transcriptomic
expression profiles are measured. Causton et al. includes a yeast gene expression series
including yeasts treated with acid, alkali, heat, hydrogen peroxide, salt, sorbital, and during
diauxic shift; Gasch et al. contains yeasts treated with amino acid starvation, diamide, DTT,
exposure to peroxide, menadione, nitrogen depletion, osmolarity, and temperature shifts;
Rosetta corresponds to 300 diverse mutations and chemical treatments; GSE60613 analyzes
the stress-activated signaling network; GSE11452 corresponds to chemostat cultures under
55 different conditions. As shown in the data preprocessing step in Fig. 3.2, within each
individual study we first deleted genes and samples with more than 10% and 30% missing
values respectively, imputed the missing values with K-nearest neighbors algorithm [Altman,
1992], and quantile normalized the samples [Amaratunga and Cabrera, 2001]. We further
performed unbiased filtering within each study to filter out non-expressed genes (lowest 35%
of mean expression) and non-informative genes (lowest 35% of expression variances). Finally,
our data sets include 1,770 overlapped genes across five studies and 45, 173, 300, 67, and
170 samples for study Causton, Gasch, Rosetta, GSE60613, and GSE11452, respectively.
As an in silico biological evaluation of the LA triplets, we downloaded yeast protein-
protein interaction (PPI) database from Saccharomyces Genome database (SGD) [Cherry















































Figure 3.2: A process map of the genome-wide application of the MetaMLA algorithm.
applied pathway enrichment analysis on two databases: Gene Ontology (GO) [Cherry et al.,
2011] and KEGG [Kanehisa et al., 2016] databases and obtained 1,398 GO terms and 95
KEGG pathways with at least five genes. Additionally in order to test how co-regulated genes
are enriched in transcription factor (TF) binding data, we downloaded a TF binding gene
sets from YEASTRACT database [Teixeira et al., 2013] and 96 gene sets with 5-200 validated
genes were selected for further enrichment analysis. Fisher’s exact test [Upton, 1992] was
used for pathway enrichment analysis. The P -values were corrected by Benjamini-Hochberg
(BH) algorithm [Benjamini and Hochberg, 1995] and the significance level was set to be
α = 0.05.
3.2.2 Liquid association methods (LA and MLA) for a single study
Li [2002] introduced the concept of “liquid association” and defined the LA score for a gene
pair X1 and X2 given a scouting gene X3 as LA(X1, X2|X3) = Eg′(X3), where g(x3) =
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E(X1X2|X3 = x3) and g′(x) is the first derivative of g(x). After standardizing the three
gene expressions to fit Gaussian assumption and applying Stein’s lemma, they proposed a
computationally efficient estimator by L̂A =
∑n
l=1X1lX2lX3l/n, where n is the total number
of observations (samples) and X1l, X2l, and X3l are the lth observations for genes X1, X2,
and X3, respectively.
Ho et al. [2011] proposed a modified LA (MLA) method by MLA(X1, X2|X3) = Eh′(X3),
where h(X3) = ρ(X1, X2|X3), h′(x) is the first derivative of h(x), and ρ is the Pearson correla-
tion coefficient. They proposed a direct estimation of MLA score by M̂LA =
∑M
j=1 ρˆjX¯3j/M ,
where M is the number of bins over X3, X3j is the sample mean of X3 within bin j, and ρ̂j
is the correlation of the LA pair X1 and X2 in bin j. A key advantage of the MLA estimator
is the capability of performing hypothesis testing H0 : MLA(X1, X2|X3) = 0 by a Wald test
statistics TMLA = M̂LA/SE(M̂LA) to assess the P -value, where SE(M̂LA) is the standard
error of M̂LA.
3.2.3 MetaMLA and MetaLA methods
In this section, we extend the original three-product-moment LA method [Li, 2002] and the
model-based MLA method [Ho et al., 2011; Gunderson and Ho, 2014] into a meta-analytic
scheme for combining information from multiple transcriptomic studies.
Suppose that we have K studies. For a gene triplet t: (X1, X2, X3), if the LA scouting
gene is Z = Xi(i = 1, 2, 3), after standardizing all the three genes to have mean 0 and
variance 1 and the scouting gene to follow normal distribution, the direct estimation of the





t,j /M , where M is the number of bins, ρ̂
(k,i)
t,j is the sample Pearson correlation
coefficient of the LA pair in bin j when the scouting gene Z is Xi in triplet t, and z
(k,i)
t,j is the









t ) is the standard error of M̂LA
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t for k = 1, · · · , K and i = 1, 2, 3.
The MetaMLA statistic combines individual study MLA statistics T
(k,i)




















t provides standardization according
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to the variance of MLA scores across studies. s0 is a fudge parameter to avoid obtaining
large mMLA score caused by very small s
(i)
t values, which happens frequently in genome-
wide screening. In our yeast data sets, suppose N is the total number of triplets for the
hypothesis testing. We choose s0 to be 10 × med{s(i)t , i = 1, 2, 3 and t = 1, · · · , N}
(where med(·) means the median) to guarantee the stability of the test statistics, especially
when sample size is small. The standardization by dividing the variance in the T
(k,i)
MLA,t score
considers both sample size and sample heterogeneity effects in single studies. For a study of
large sample size, the standard deviation of MLA score is usually smaller and thus generates
larger T
(k,i)
MLA,t score. For a study containing large biological variation or considerable outliers
in samples, the standard deviation of MLA score is large and results in smaller T
(k,i)
MLA,t score.
The MetaLA statistic can be defined similarly with the MetaMLA statistic. The es-
















2l , and X
(k)
3l are the lth observations for genes X1, X2, and X3 in study k, respec-
tively. The MetaLA statistic combines individual study LA scores L̂A
(k)
t and is defined as
mLAt = L̂A
(k)
t /(st + s0) where L̂A
(k)





t , k = 1, 2, · · · , K
}
, respectively. st provides standardization according to the vari-
ance of LA scores across studies. s0 is a fudge parameter to avoid obtaining large mLA score
caused by very small st values.
3.2.4 Hypothesis testing and inference for MetaMLA and MetaLA




t = 0,∀i ∈ {1, 2, 3}
↔ H1 : ∃i ∈ {1, 2, 3}, s.t. MLA(i)t 6= 0,
where i = 1, 2, 3 corresponds to LA scouting gene Z = Xi (i = 1, 2, 3). The null hypothesis
represents all zero liquid associations no matter which one of X1, X2, and X3 acts as the





The distribution of Tt under the null hypothesis can be obtained by randomly permuting
the samples of the LA scouting gene Z when calculating each mMLA
(i)
t in the Tt statistics.
We repeat the permutation for B times and use the resulting B × N permuted values of
T
(b)







t ≥ Tobs)/(B×N), where Tobs is the observed value of the test statistic. The
P -values are corrected by Benjamini-Hochberg (BH) algorithm [Benjamini and Hochberg,
1995] and the false discovery rate is set to be α = 0.01. Since the number of possible triplets
N is usually very large, a small B is needed (B = 40) and used in the paper. We note that
theoretically we should perform permutation for each triplet to form its own null distribution.
The computation is, however, obviously not feasible (= number of permutations × number
of triplets). In our approach, we imposed an assumption of common null distributions across
all triplets to allow affordable computation.
Based on MetaLA, the hypothesis for liquid association in the gene triplet t: (X1, X2, X3)
is H0 : mLAt = 0 ↔ H1 : mLAt 6= 0. The test statistic can be defined as Tt = |mLAt|.
The distribution of Tt under the null hypothesis can be obtained by randomly permuting the
samples inside gene X1, X2, or X3 in turn. We repeat the permutation for B times and use
the resulting B×N permuted values of T (b)t (1 ≤ b ≤ B, 1 ≤ t ≤ N) as the null distribution.






t ≥ Tobs)/(B × N), where Tobs is the
observed value of the test statistic. The P -values are corrected by Benjamini-Hochberg (BH)
algorithm [Benjamini and Hochberg, 1995] and the false discovery rate is set to be α = 0.01.
Similar to MetaMLA, B = 40 is used.
3.2.5 Filtering to reduce computation of MetaMLA
Genome-wide calculation of the liquid association is usually time-consuming and resource-
intensive for a single study [Li, 2002; Ho et al., 2011]. This problem is further aggravated
when combining multiple studies. In this section, we will develop a screening algorithm to
perform a genome-wide MetaMLA analysis with higher efficiency. As illustrated in Fig. 3.2,
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our algorithm seeks to reduce the number of triplets which need to be examined in depth in
two screening steps: bootstrap filtering and sign filtering (Fig. 3.2).
In the first bootstrap filtering step, we filter out triplets with small correlation difference
between the high and low bins. Define ρdiff to be the difference of the LA pair correlations
when scouting gene assigned to the highest and lowest bins. In the literature, the fastLA
algorithm for single study [Gunderson and Ho, 2014] has used screening procedure for fast
computing. In meta-analysis, we aim to detect triplets with consistently large or consistently
small liquid associations across multiple studies. For the triplet t: (X1, X2, X3), given the




high,t − ρ(k,i)low,t, where ρ(k,i)high,t and ρ(k,i)low,t
are the Pearson correlations when gene Z is in the high and low bins of study k, respectively.
We use the score
∑K
k=1 |ρ(k,i)diff,t|/K as the meta-filtering criteria. Since the scouting gene Z




k=1 |ρ(k,i)diff,t|)/K to order and filter out triplets that
are unlikely to have LA association. To avoid outlier effect when calculating correlations in
the bins, we propose to bootstrap [Efron and Tibshirani, 1986] samples in each study for B











diff,t , b = 1, · · · , B
)
to screen the triplets, where med(·) means taking the median. We set ρ(meta)diff,t > 0.4 as
the cutoff to keep the triplets for further testing. ρ
(meta)
diff,t can largely reduce computational
complexity for two reasons: (1) calculating ρ
(meta)
diff,t is computationally much simpler than the
MetaMLA statistic; (2) ρ
(meta)
diff,t can filter out a large percent of triplets and further reduce
the computational cost of P -value calculation in the permutation step.
In the second sign filtering step, we filter out triplets with inconsistent signs of test
statistics among meta and singleMLA. The scouting gene is chosen to maximize the test




















where I(·) is the indicator function and i0 = arg max
i=1,2,3
|mMLA(i)t |. For fair comparison, we
use the same triplets filtered by MetaMLA to perform MetaLA and single-study MLA.
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3.3 RESULTS
3.3.1 Computational reduction by filtering
Below we describe the screening result to avoid high computational load when evaluating all
possible triplets in MetaMLA. After unbiased filtering of non-expressed and non-informative
genes, we kept 1,770 genes, which led to a total number of
 1770
3
 ≈ 9.23× 108 triplets.
The computing time is demanding if we perform hypothesis testing for all possible triplets.
By applying bootstrap filtering with ρ
(meta)
diff,t > 0.4 with three bins, the number of triplets
reduced to 2.18× 107, approximately 2.36% of the original total number. Furthermore, the
sign filtering step decreased the number of the remaining triplets to 1.21 × 107, which was
only 1.32% of the total number.
Given the fact that our screening pipeline can dramatically reduce the number of triplets,
we assessed whether the filtering procedures ignored statistically significant LA triplets.
We performed MetaMLA on all the 9.23 × 108 triplets and reduced 1.32% triplets after
filtering. As shown in Table B.1, our screening steps only missed 89, 219, 375, 520, and 690
of the top 2000, 4000, 6000, 8000, and 10000 triplets obtained from full analysis without
filtering. P-values from Fisher’s exact test are almost 0 and odds ratio are between 1,000-
1,600 (Table B.1). In summary, we only missed about 5% significant triplets but saved
almost 99% of computing time to make genome-wide LA triplet screening possible. Since
filtering step also consumes computing time, we compared computing time of analyses with
filtering versus non-filtering on a small dataset of 95 genes (using stringent selection criteria
by removing genes with small means and small variances). By using five computing threads
(Intel Xeon E7-2850), computing time for analyses with filtering versus non-filtering saved
about 88% of computing time (16.3 minutes versus 134.6 minutes).
In general, filtering out potentially non-significant triplets will gain statistical power (van
Iterson et al. [2010] and Bourgon et al. [2010]). In other words, we can detect more significant
triplets under the same FDR control. To demonstrate the empirical effect of filtering in real
data, we randomly selected 500 genes from the five Yeast studies and re-ran our MetaMLA
algorithms by both filtering and non-filtering pipelines. Fig. B.1 shows that for a given
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reasonable FDR (for example: 0.005 and 0.01), filtering pipeline can detect more significant
triplets than full studies as we expected.
3.3.2 MetaMLA detects more over-represented pathways
We performed pathway enrichment analysis using GO and KEGG for all the genes from top
m significant triplets (m = 200, 300, · · · , 1000) selected by the single study MLA, MetaMLA,
and MetaLA. Fig. 3.3 shows the numbers of enriched GO terms and KEGG pathways for
different top numbers of triplets under FDR=0.05 threshold. MetaMLA (solid square line)
consistently performed better than any single-study MLA (five dash lines) and MetaLA (solid
rhombus line) method by detecting more enriched pathway. Jitter plots of q-values of the
GO terms and KEGG pathways for the top 500 triplets at minus log 10 scale are further
shown in Fig. B.2. Since single MLA and MetaMLA method can differentiate LA scouting
gene Z, similar pathway enrichment analysis were done only for Z genes from the top triples
(Fig. B.3 and B.4).
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Figure 3.3: The number of enriched gene sets for all the genes from different numbers of top
triplets detected by meta and single analysis. (A) is for GO terms and (B) is for KEGG
pathways.
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3.3.3 MetaMLA provides more consistent biomarker and pathway results with
single study analyses
Fig. 3.1 (A) shows an example with LA association in the first study (correlation dropped
from 0.692 to -0.79 for high and low expression groups of the LA scouting gene YGR175C)
but fails to reproduce in the remaining four studies. Such an LA association with failed
reproducibility is likely a false positive. Fig. 3.1 (B) demonstrates another example with
consistent LA association in all five studies (correlation dropped significantly for high and
low expression groups of YDR519W). In order to inspect agreement of top LA triplets across
pairwise studies, Fig. B.5 and B.6 show scatter plots of test statistics and rank correlations
of the pairwise top 1000 triplets. MetaMLA method combines information from all single
studies. Conceptually, MetaMLA can provide more consistent results with single study
MLA than results among single study MLA. In Fig. 3.4 (A), we examined pairwise overlap
of detected top 1,000 triplets from the five single-study MLA and the MetaMLA. The result
shows zero overlapping in all single-study MLA top triplets. (We also tried other top number
of triplets in Fig. B.7 and they all shows out small overlap among single studies.) On the
other hand, top triplets from MetaMLA have much higher percentage of overlapping with
results from each single-study MLA.
We next calculated the number of overlaps of enriched GO terms and KEGG pathways
when we used all the genes from the top 500 triplets from each MLA analysis for pathway
enrichment. The results are shown in Fig. 3.4 (B) and (C). Numbers on the diagonal cells
demonstrate the number of enriched GO or KEGG pathways from each single-study MLA
and MetaMLA. (Similarly, overlapped pathways by only Z genes from the top 1000 triplets
are shown in Fig. B.8). Similar to overlapped triplets in Fig. 3.4 (A), we observed much
higher overlapped pathways between the MetaMLA result and each single-study MLA result
than results between pair-wise single-study MLA. For example, study Causton detected 27
enriched GO terms, among which 8, 9, 6 and 9 pathways overlapped with results from the
other four single-study MLA. Notably, it has 12 and 15 GO terms overlapped with MetaLA












































































































































































































































































































Figure 3.4: Overlap of meta and single analysis. (A) is for the number of overlapped triplets
for the top 1000 significant triplets; (B) is for the number of overlapped enriched GO terms
using all the genes from top 500 triplets for gene set enrichment analysis; (C) is for the
number of overlapped enriched KEGG pathways using all the genes from top 500 triplets for
gene set enrichment analysis.
3.3.4 MetaLA and MetaMLA provide more stable results
Below we apply subsampling and bootstrap techniques to compare stability for LA triplets
detected by single-study MLA, MetaLA and MetaMLA. Fig. 3.5 (A) and (B) show the
number of overlapped triplets between top triplets detected by original full dataset and
subsampled data sets (90% and 80%, respectively). The numbers of top triplets are displayed
on the x-axis and the y-axis is for the overlapping numbers. The result shows much better
reproducibility of top triplets detected by subsampled data in MetaMLA (solid square line)
and MetaLA (solid rhombus line) compared to single-study MLA (five dash lines). Similarly,
comparison with bootstrapped data in Fig. 3.5 (C) shows similar trend. In summary,
MetaMLA provides better stability in detecting top LA triplets, when compared to single-


















































































































Figure 3.5: The number of overlapped top significant triplets between the original data set
and the subsampled or bootstrap data sets. (A) and (B) are for the results of means and
standard errors of ten times subsampling for the proportion of 0.90 and 0.80, respectively;
(C) is for the results of means and standard errors of ten times bootstrap.
3.3.5 Pathway enrichment analysis and network visualization
In Section 3.3.2 - 3.3.4, although MetaLA provides more stable result than MetaMLA 3.3.4, it
detects much fewer enriched pathways (Section 3.3.2) and generates less consistent biomarker
and pathways with single studies (Section 3.3.3). As a result, we will focus on MetaMLA
for further biological investigation in this subsection.
To test how the liquid association genes detected by MetaMLA method are consistent
with transcription factor (TF) binding, we downloaded the TF binding gene sets from the
YEASTRACT database [Teixeira et al., 2013] and selected 96 gene sets with 5-200 genes.
Among these 96 TF genes, Hog1 (YLR113W) has the highest frequency among all the genes
from the top 20000 triplets detected by MetaMLA method. Genes inside the same triplet
as Hog1 are enriched in Hog1 binding gene sets (p = 0.027). More significantly, Hog1 is
also the most frequent gene among the LA scouting gene Z in the top 100000 triplets.
Genes regulated by Hog1 (inside the same triplets) are more significantly enriched in Hog1
binding gene sets (p = 1.44E − 5). Table B.2 shows the top enriched TF binding gene sets.
Among them, Hot1 is another enriched gene sets (p = 7.67E − 6) and Alepuz et al. [2003]
shows that Hot1 targets on Hop1p to osmostress responsive promoters and Hog1 mediates
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recruitment/activation of RNAPII at Hot1p-dependent promoters. The analysis shows that
top triplets selected by MetaMLA method are highly consistent with known TF regulation
pattern.
Table 3.1 shows 18 significantly enriched KEGG pathways with hierarchical structure
using all the genes from top 500 triplets selected by MetaMLA. Pathway enrichment using
GO database identified 68 GO terms (Table B.3). Since the five transcriptomic studies
contain yeast samples treated with different environmental conditions and mutations, we
observed many pathways related to energy metabolism (q = 5.67E − 12), carbohydrate,
metabolism (q = 1.40E − 8), amino acid metabolism (q = 5.87E − 8), and translation
(q = 0.0065).
Table 3.1: Enriched KEGG pathways and their hierarchical categories for all the genes from
top 500 triplets selected by MetaMLA method.




Metabolism 1.53E-23 1.85E-21 2.69 200 835
Energy metabolism 9.37E-14 5.67E-12 5.36 43 122
sce00190 2.03E-12 8.21E-11 7.91 29 72 Oxidative phosphorylation
sce00680 0.007957 0.041109 3.49 8 28 Methane metabolism
Carbohydrate metabolism 4.64E-10 1.40E-08 2.86 62 229
sce00620 1.91E-06 3.30E-05 5.53 17 39 Pyruvate metabolism
sce00630 3.15E-05 0.000423 6.14 12 26 Glyoxylate and dicarboxylate metabolism
sce00020 6.30E-05 0.000763 4.99 13 32 Citrate cycle (TCA cycle)
sce00010 0.000527 0.004249 2.99 17 58 Glycolysis / Gluconeogenesis
sce00051 0.005765 0.034881 3.76 8 25 Fructose and mannose metabolism
sce00030 0.007158 0.039369 3.23 9 28 Pentose phosphate pathway
Amino acid metabolism 2.42E-09 5.87E-08 3.06 51 178
sce00260 6.40E-08 1.29E-06 8.99 16 32 Glycine, serine and threonine metabolism
sce00270 0.000146 0.001468 4.44 13 36 Cysteine and methionine metabolism
sce00250 0.002637 0.016791 3.60 10 30
Alanine, aspartate and
glutamate metabolism
Lipid metabolism 0.000913 0.006501 2.11 29 126
sce00100 0.000183 0.001705 6.89 9 17 Steroid biosynthesis
sce01040 0.000454 0.003927 12.21 6 11 Biosynthesis of unsaturated fatty acids
sce00062 0.002175 0.014623 10.16 5 8 Fatty acid elongation
Metabolism of cofactors and vitamins 0.011664 0.052272 1.80 24 117
sce00670 0.008629 0.041763 4.57 6 15 One carbon pool by folate
Genetic Information Processing 0.214481 0.447452 1.10 114 1123
Translation 0.000861 0.006501 1.59 70 682
sce03010 9.42E-05 0.001036 2.22 37 181 Ribosome
Folding, sorting and degradation 0.105526 0.283748 1.27 41 263
sce03050 0.008154 0.041109 2.91 10 35 Proteasome
Cellular Processes 0.718769 0.995721 0.92 45 382
Transport and catabolism 0.010656 0.049591 1.61 36 194
sce04145 2.96E-05 0.000423 5.07 14 36 Phagosome
To investigate further the identified LA association gene interactions, we chose among
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the top 20,000 LA triplets (q < 6.64E − 5) and included a total of 41 triplets with all
three genes involved in the metabolism category (q = 1.85E − 21 in Table 3.1) for network
visualization (Fig. 3.6). Genes within one triplet are connected by edges in the same color.
The dashed line represents reported interactions or regulations in the PPI database. In this
network, there are totally four interactions validated by PPI database, more enriched than
a randomly generated PPI database (0.69 random interactions on average, with P -value















































































Metabolism of cofactors and vitamins
Metabolism of other amino acids
Metabolism of terpenoids and polyketides
Nucleotide metabolism
Gene
Figure 3.6: Gene network associated with metabolism. Genes within one triplet are con-
nected by edges in the same color. The dash line means that the edge is in the PPI database.
The small circle connected with the gene means that this gene is in the corresponding sub-
category.
In Fig. 3.6, we observed a cluster of gene modules related to carbohydrate metabolism
(purple background circle in Fig. 3.6; almost all genes annotated with gray dots). IDH2 and
BDH2 are two notable hub genes that have many LA association with other neighboring
genes. IDH2 is a subunit of mitochondrial NAD(+)-dependent isocitrate dehydrogenase,
a key complex in tricarboxylic acid (TCA) cycle to catalyze the oxidation of isocitrate to
alpha-ketoglutarate [Reinders et al., 2007]. BDH2 is a putative medium-cahin alcohol dehy-
drogenase [Dickinson et al., 2003]. In carbohydrate metabolism, pyruvate is the main input
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for a series of chemical reactions for aerobic TCA cycle. In the subnetwork, CDC19 is a key
pyruvate kinase, which coverts phosphoenolpyruvate to pyruvate [Xu et al., 2012; Byrne and
Wolfe, 2005], and its physical protein-protein interaction with IDH2 has been previously re-
ported [Gavin et al., 2006]. In addition, PDC5 is a minor isoform of pyruvate decarboxylase
and PDC1 is a major of three pyruvate decarboxylase isozymes to decarboxylate pyruvate to
acetaldehyde [Dickinson et al., 2003]. ENO2 is also a phosphopyruvate hydratase involved
in pyruvate metabolism to catalyze 2-phosphoglycerate to phosphoenolpyruvate during gly-
colysis [McAlister and Holland, 1982; Byrne and Wolfe, 2005]. All these genes from the top
MetaMLA triplets are potentially co-regulated with functional annotation from the carbo-
hydrate metabolism pathway. However, if we examine the direct gene-gene Pearson corre-
lations, the pair-wise correlations are low and the co-expression analysis will fail to identify
association among these genes (see Table B.4).
3.4 CONCLUSION AND DISCUSSION
In this paper, we proposed two meta-analytic methods (MetaLA and MetaMLA) for liq-
uid association analysis combining multiple studies. We used the mean of the singleMLA
test statistics as the main part of the MetaMLA statistic and the standard deviation to
penalize the inconsistent patterns among different studies. On the genome-wide application,
we proposed to screen genes by bootstrap filtering and sign filtering (Fig. 3.2) to reduce
the computation load. In the yeast data sets, we reduced more than 98% of the triplets
for the hypothesis testing and captured 94-95% of the top triplets with large MetaMLA
statistic. Compared with singleMLA method, MetaMLA can provide stronger pathway en-
richment signal, more consistent results with single-study analysis, and more stable results
with data subsampling or bootstrapping. Although MetaLA generated more stable results
than MetaMLA, it detected less enriched pathways and is less consistent with single study
analysis. Among the top significant triplets selected by MetaMLA, we constructed a gene reg-
ulatory network visualization to investigate the complex three-way conditional associations.
The result identifies a subnetwork in carbohydrate metabolism network, which otherwise
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cannot be identified by traditional pair-wise co-expression analysis. We identified validation
in protein-protein interaction and focused functional annotation in TSA cycle.
The LA and MLA methods to detect liquid association triplets have their pros and cons.
On one hand, the LA score by a three-product estimation on normalized gene intensities is
much easier to compute than the model-free estimation of MLA score. However, MLA is more
accurate when interdependency among the triplet (i.e. conditional mean and variance of two
genes depend on the third gene) exist and such interdependency is theoretically ignored by
the LA method. Additionally, MLA also provides systematic inference to assess p-values and
false discovery rate control. To circumvent computational burden in MetaMLA, our proposed
two-stage filtering can significantly reduce computing time. In this paper, we demonstrate
genome-wide screening on all possible gene triplets. To further reduce computational load,
one may apply pre-selected scouting genes from prior biological knowledge, transcription
factor or protein-protein interaction databases.
Our meta-analytic framework has the advantage to stablely combine multiple studies
from different microarray or next-generation sequencing platforms. Potential heterogeneity
from platform, batch effect or measurement scaling issues are automatically standardized in
the meta-analysis. In the literature, it has been well-acknowledged that simple correlation
and co-expression analysis are not sufficient to describe the complex system of gene regu-
lation. Applying advanced association models elucidates novel regulatory mechanisms and
meta-analysis by combining multiple transcriptomic studies will greatly reduce false posi-
tive findings. Our proposed meta-analytic liquid association methods help accurately detect
complicated three-way interactions and regulatory mechanisms.
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4.0 AIM 3. META-ANALYTIC PLAID MODEL FOR DETECTING BICLUSTERS 
WHEN COMBINING MULTIPLE TRANSCRIPTOMIC STUDIES
The majority of the text in this chapter comes from a manuscript prepared for submission.
4.1 INTRODUCTION
In the past two decades, high-throughput experimental technologies including microarray and
next-generation sequencing have generated abundant high-dimensional data and introduced
new statistical and computational challenges. In the analysis of transcriptomic data from
microarray and RNA-seq, cluster analysis is a powerful unsupervised machine learning tool to
group objects (i.e. genes or patients) by proximity of expression patterns when the underlying
true class labels are not known [D’haeseleer, 2005]. When clustering genes, the purpose is to
identify modules of highly co-expressed genes that likely are co-regulated or share common
biological functions. When clustering patients, we aim to identify patient groups of similar
expression patterns to form disease subtypes that are potentially of clinical significance
with different disease mechanism, treatment response or survival outcome. Many classical
clustering methods as well as new inventions have been applied or developed to the cluster
analysis of expression profiles. Methods such as hierarchical clustering [Eisen et al., 1998],
K-means [Hartigan and Wong, 1979], self-organizing map [Tamayo et al., 1999], model-based
approaches [McLachlan et al., 2002] and Bayesian clustering [Medvedovic et al., 2004] have
been widely used. Resampling approaches have been applied to improve clustering stability
and consistency [Monti et al., 2003; Tibshirani and Walther, 2005; Tseng and Wong, 2005].
The concept of excluding scattered genes or samples from cluster assignment was introduced
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to improve clustering tightness and quality [Tseng and Wong, 2005; Tseng, 2007; Maitra and
Ramler, 2009]. Several comparative studies have been conducted to evaluate performance of
different clustering methods in microarray data (see Datta and Datta [2003] and Thalamuthu
et al. [2006] for gene clustering and de Souto et al. [2008] for sample clustering).
The aforementioned “one-way” clustering, however, has its own drawbacks. In most com-
plex diseases, patients are heterogeneous and unknown disease subtypes often exist. Many
gene modules may be co-expressed only in a subset of samples. To this end, biclustering
methods have been developed for identifying clusters with subset of genes and subset of sam-
ples simultaneously. A variety of biclustering methods have been developed in the literature.
Cheng and Church [2000] was the earliest to employ biclustering in gene expression data.
They used a greedy algorithm to find biclusters assuming uniformly expressed intensities in
the background. Lazzeroni and Owen [2002] introduced a plaid model on the assumption
that the matrix expression levels are the superposition of each bicluster layers. Martella
and Vermunt [2013] developed a mixture of structural equation models (SEMs), which is a
more general model to detect both clustering and biclustering patterns in gene expression
matrices [Martella et al., 2008]. Among many other popular algorithms, Spectral [Kluger
et al., 2003], xMOTIFs [Murali and Kasif, 2003] and Bayesian Biclustering [Gu and Liu,
2008] were developed with different bicluster pattern targets and for different biological pur-
poses. Multiple reviews and comparative studies have comprehensively evaluated different
biclustering methods [Eren et al., 2013; Bozdag˘ et al., 2010; Madeira and Oliveira, 2004;
Prelic´ et al., 2006].
As microarray and NGS experimental costs continue to drop over the years, tremen-
dous amount of transcriptomic data are available in public databases. As each single study
usually contain only moderate number of samples, its cluster analysis is deemed unstable
and may be biased by study-specific features such as cohort bias or experimental protocol.
An increasing trend of combining multiple transcriptomic studies for meta-analysis not only
increases statistical power but also generates more robust and consistent results that more
likely can be validated in independent cohorts [Tseng et al., 2012; Richardson et al., 2016]. In
the literature, transcriptomic meta-analysis have mostly focused on detecting differentially
expressed genes and associated pathways. In this paper, we propose a meta-analytic plaid
75
model to integrate multiple transcriptomic studies for bicluster detection. From simulations
and a real example of five breast cancer expression profiles (Table 4.1), we show that single
study biclustering generates unstable results that are difficult to validate in independent
studies. Our meta-biclustering method produces more stable and consistent results that
reveal interesting biological insights in potential disease subtypes.
Table 4.1: Five breast cancer expression data information
BRCA sample GSE2034 GSE7390 GSE11121 TCGA METABRIC
Reference Wang et al. [2005] Desmedt et al. [2007] Schmidt et al. [2008] Network et al. [2012] Curtis et al. [2012]
Platform Affymetrix Affymetrix Affymetrix Agilent Illumina
Number of genes 12704 12704 12704 17814 19396
Number of samples 260 164 161 533 1981
Mean intensity 6.797± 1.71 5.523± 1.84 6.552± 1.79 0.003± 1.34 6.960± 1.70
4.2 METHODS
4.2.1 Data sets and databases
In order to evaluate the performance of biclustering, we generated simulation data with
known underlying truth. First of all, we confined our study to four types of genes. They
are (1) consistent genes : genes that are relevant to biclusters of all the studies; (2) prevalent
genes : genes that are relevant to biclusters in all the studies except for the last one; (3)
study-specific genes : genes that are relevant to biclusters in only one study; (4) irrelevant
genes : genes that are irrelevant to biclusters in all studies. For each simulation setting, we
synthesized 4 studies with 500 genes and 100, 100, 80 and 70 samples, respectively. The
simulated biclusters are a superposition to the background value with 50 genes and 40, 30,
25 and 25 samples for each study. Table C.1 shows information of simulation parameters
and details.
Five breast cancer (BRCA) data sets in Table 4.1 will be used to test our meta-analytic
method: GSE2034 [Wang et al., 2005], GSE7390 [Desmedt et al., 2007], GSE11121 [Schmidt
et al., 2008], TCGA [Network et al., 2012] and METABRIC [Curtis et al., 2012]. These
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five studies were generated by different platforms and their intensity ranges differ from each
other. It is worth noting that METABRIC, among all the data sets has access to rich
clinical and survival information, which is particularly helpful for our evaluation of detected
biclusters. For pre-processing, we filtered out genes with missing values and only kept the
overlapped genes in all five studies. Then we quantile normalized the samples within each
single study [Amaratunga and Cabrera, 2001]. For the next step, we performed meta-filtering
method used in Wang et al. [2012b] and filtered out non-expressed genes (lowest 50% of mean
expression) and non-informative genes (lowest 50% of expression variances). As a result, our
data sets include 2648 genes across all the studies and 260, 164, 161, 533 and 1981 samples
for the five studies, respectively.
4.2.2 The plaid model for single study bicluster detection
Plaid model is a popular and good-performing bicluster detection algorithm to detect over-
lapped biclusters from transcriptomic data [Lazzeroni and Owen, 2002] . It can discover
higher proportion of enriched biclusters compared with other algorithms [Eren et al., 2013].
Assume Yij is the expression intensity of gene i in sample j, where i = 1, . . . , n, j = 1, . . . , p,
n and p are the total numbers of genes and samples. In plaid model, it assumes that the





=(µ0 + αi0 + βj0) +
K∑
k=1
ρikκjk(µk + αik + βjk) + ij,
where k is the layer index and k = 0 refers to the overall background layer; the formula
θijk = µk + αik + βjk represents estimated intensity to be the sum of mean (µk), gene (αik)
and sample (βjk) effects for gene i in sample j of the kth layer; ρik and κjk are binary
membership partition parameters for gene i and sample j respectively, with 1 indicating
inside the layer and 0 for outside the layer; ij refers to the error term.
To estimate the parameters of the kth layer, the algorithm first subtracts the previous
(k − 1) estimated layers. The remaining expression intensity can be written as, Zijk =
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Yij − θij0 −
∑k−1
k′=1 θijk′ρik′κjk′ . Then the objective function for the k








[Zij − (µ+ αi + βj)ρiκj]2 ,







where the subscript k is eliminated for short.
Lazzeroni and Owen [2002] proposed this plaid model and estimated the parameters by
straightforward Lagrange multiplier. As a further step, Turner et al. [2005a,b] improved this
model and implemented binary least square algorithm to update the parameters. Then they
further pruned the biclusters to screen out non-informative genes or samples by pruning
parameter ν1 and ν2,
ρ˜i =
 1 if ρˆi = 1 and
∑
j:κˆj=1






 1 if κˆj = 1 and
∑
i:ρˆi=1






Plaid model performs well in detecting biclusters within single study. In this paper, we
propose a meta-biclustering method to extend this model to meta-analytic framework to
detect biclusters among multiple cohorts simultaneously.
4.2.3 Penalized objective function for regularization and meta-biclustering
First of all, we improved the plaid model by integrating the pruning step into the objective






























We modify the pruning step in Eq. 4.1 from Turner et al. [2005a,b] by substituting
j : κˆj = 1 to j ∈ {1, 2, . . . , p}, that is,
ρ˜i =
 1 if ρˆi = 1 and
∑p







 1 if κˆj = 1 and
∑n







It can be proved that the penalized objective function in Eq. 4.2 is equivalent to the modified
form of the pruning steps in Equ. 4.3 (see Appendix for proof).
Next, we extend the penalized objective function in Eq. 4.2 into a meta-analytic frame-









































+ λ · Ω. (4.4)
Here Ω is a meta-term to borrow information across studies and control consistency of
gene selection and/or gene effect sizes across studies. λ is a tuning parameter for weight
of the meta-term where larger λ gives higher penalty to the inconsistent gene partitions
among multiple studies, and vice versa. In this paper, we have compared seven options
of the meta-term Ω (see Table 4.2) and compared their performance in Section 4.3.1 using
extensive simulations.
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i for all the studies
4.2.4 Optimization of proposed objective function
Parameters of the proposed MetaBiclust objective function (Eq. 4.4) can be estimated by
using binary least square algorithm, which is similar to the single-study plaid model proposed
by Turner et al. [2005a,b].
Step 1: Pre-processing. Normalize each study matrix to mean 0 and standard deviation




Step 2: Initialization. Implement K-means clustering with k = 2 and select all the genes
(or sample) in the smaller cluster for gene (or sample) initialization.
Step 3: Expectation-maximization (EM) iteration. Estimate the parameters by EM al-
gorithm, regarding the gene and sample selection as a missing data problem. The objective
function is first optimized within each single cohort (τ1 = τ2 = λ = 0), then optimized
without gene and sample selection penalization (τ1 = τ2 = 0), and finally updated using the
full objective function. The parameters can be updated iteratively as follows,
M-step:































































That is to say, main, gene and sample effect can be updated by the linear regression
model (M-step), and partition parameters ρ and κ are updated by selecting the best binary









j ) iteratively until convergence or reaching the maximum updating step cutoff.
Multiple initials for K-means in Step 2. are tested to generate the best objective score and
to alleviate local minimum problem.
4.2.5 Selection of parameters
In this section, we discuss selection of τ1, τ2 and λ. τ1 and τ2 are two pruning parameters
that can be selected by maximizing the gap statistic, borrowing the idea from cluster number
selection [Tibshirani et al., 2001]. We define,
max
(τ1,τ2)
Gap(τ1, τ2) = Enull[obj(τ1, τ2)]− obj(τ1, τ2),
where obj(τ1, τ2) is the objective function score given τ1 and τ2 in Eq. 4.4. The null expected
objective score Enull[obj(τ1, τ2)] is calculated as the average of B times permutations under
null. The algorithm performs grid search of τ1 and τ2 by balancing computing and resolution,
and finally identifies the best (τˆ1 τˆ2) that maximizes the gap statistic.
Parameter λ helps to adjust the consistency of the genes selection from multiple studies.
High λ means large penalty on the inconsistency, while low λ gives less penalty. To the
extreme, λ =∞ can guarantee exactly the same gene selection, while λ = 0 represents single
study analysis with equal feature selection parameters τ1 and τ2 in each study.
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4.2.6 Bicluster evaluation
We evaluate biclustering results from two aspects. For synthetic data with known underlying
truth, we use Jaccard coefficient [Eren et al., 2013] to define the similarity between the












b2| represents element numbers of the intersection and union of the
two biclusters, respectively.
For real data without known biclustering truth, we implemented indirect evaluation for
both gene and sample selection. We apply pathway enrichment analysis on curated pathway
databases collected by MSigDB (version 5.2), including: chemical and genetic perturbations,
Canonical pathways, BioCarta, KEGG and Reactome. We filter out pathways with less than
5 or greater than 200 genes. Finally, 3384 gene sets are used for pathway enrichment analysis
by Fisher’s exact test [Upton, 1992]. Enrichment p-values are then adjusted by Benjamini-
Hochberg (BH) algorithm [Benjamini and Hochberg, 1995] and the false discovery rate (FDR)
is set to be 0.05. For METABRIC study [Curtis et al., 2012], both clinical and survival
information are available for cluster evaluation. For a given bicluster, we test association of
sample selection with with clinical information (e.g. ER positive versus negative) by Fisher’s
exact test. Kaplan Meier curve and log-rank test [Mantel, 1966] are used in the METABRIC
cohort for testing survival difference between samples inside and outside the bicluster.
4.3 RESULTS
4.3.1 Selection of meta-term Ω
For the MetaBiclust algorithm, we expect to select similar bicluster gene sets among multiple
cohorts. Seven meta-terms (Table 4.2) were proposed in the objective function to penalize
inconsistent bicluster gene selection. Fig. 4.1 compares the performance of different meta-
terms in two scenarios (with pruning parameter τ1 = τ2 = 0.05). In the consistent +
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prevalent gene simulation (Fig. 4.1A, see simulation details in section 4.2.1), three types
of gene sets can be used as truth to evaluate the Jaccard similarity: truth 1 only contains
the simulated consistent genes; truth 2 consists of the true consistent and prevalent gens
for each study; and truth 3 includes both consistent and prevalent genes for all the studies.
In this scenario, we aimed to detect biclusters composed by both consistent and prevalent
genes in all the cohorts, so truth 1 and truth 3 are preferable. Fig. 4.1 shows that the
2nd and 7th meta-term overall performs better than the others. In the second scenario,
consistent + study-specific genes were simulated to evaluate the performance (Fig. 4.1B).
Similar to previous simulation, three types of gene set selections can play roles as underlying
truth, except that now we substitute the prevalent genes by study-specific genes. In order to
detect consistent gene sets but not influenced by study-specific genes, we prefer to compare
the results using truth 1. Fig. 4.1 shows that the 7th meta-term performs best for all
different λ settings. Alternatively, Fig. C.1 compared the results without pruning steps
(τ1 = τ2 = 0) and found similar performance trend. These two simulation results lead to














) in the meta-
biclustering objective function to encourage consistent and prevalent genes but discourage
study-specific genes.
4.3.2 Meta-analysis increases bicluster detection accuracy
In order to compare bicluster detection performance between single-study and meta-analysis,
we simulated 4 studies with consistent bicluster gene partition (described in section 4.2.1)
and tried a series of λ value to evaluate the accuracy. When λ equals to zero, each single
study detected their biclusters independently without meta-term penalty. Small λ value
penalizes less on the inconsistent bicluster gene selection across studies, while larg λ value
leads to more consistent gene selection results. Fig. 4.2A shows the Jaccard value of the
biclusters detected from 4 simulation data matrices when given different λ values (0, 50,
100, 1000 and 10000). The mean and SD Jaccard values were calculated by 100-times
simulation repeats. The x-axis σ0 represents the background noise. Given that the true




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.1: Comparison of seven meta terms performance on (A) consistent + prevalent
gene simulation; (B) consistent + study-specific gene simulation with pruning steps. For
consistent + prevalent gene simulation, truth 1 means only using consistent genes as the
underlying truth, truth 2 means using exactly the consistent genes and prevalent genes
inside each study, and truth 3 means using consistent + prevalent genes as the truth for all
studies. For meta analysis, truth 3 is preferred that both consistent and prevalent genes are
preferred to be detected. For consistent + study-specific gene simulation, truth 1 means only
using consistent genes as the underlying truth, truth 2 means using exactly the consistent
genes and study-specific genes inside each study, and truth 3 means using consistent + study-
specific genes as the truth for all studies. For meta analysis, truth 1 is preferred that only
common genes are preferred but not the study-specific genes.
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(λ > 0) overall performed better than single-study (λ = 0), especially when the noise was
large. Larger λ led to higher Jaccard value because gene selections were controlled by more
strict consistency penalties among multiple studies. For example, when σ0 = 1.5, biclusters
detected from single-study (red line, λ = 0) only reached Jaccard values that were smaller
than 0.6, while meta-analysis performed much better. When setting an extreme λ value, for
example, 10000 (purple line), the Jaccard value was higher than 0.85. Notice that, when
λ hit a certain threshold, gene selections for all the studies were exactly the same and the
performance would not be improved if λ increased further. For example, in Fig. 4.2A, the
λ = 1000 line (blue) were almost identical to λ = 10000 line (purple). It is also worth noting
that, larger lambda does not necessarily guarantee better performance if prevalent genes and
study-specific genes are of interest. For example, Fig. 4.1 and C.1 shows the performance
of consistent + prevalent gene and consistent + study-specific gene simulations for different
lambda settings. In these simulations, Jaccard performance may increase and then drop as
λ becomes large. This is because very large λ decreases power to detect study-specific genes.
In the following analyses of this paper, we concentrate on detection of only consistent genes
to maximize chance of independent validation. As a result, λ = 10000 is set to encourage
consistent genes selection.
We further assessed detection power of single study analysis or MetaBiclust when smaller
sample sizes are available. Fig. 4.2C shows the Jaccard accuracy of detected biclusters with
different percentage of subsampling. For example, there were 100, 100, 80 and 70 samples
in the four simulated studies. When subsampling percentage is 30%, sample sizes reduced
to 30, 30, 24 and 21. Jaccard index of single-study analysis dramatically reduced to ∼50%
while Jaccard of MetaBiclust remained as high as 0.85.
4.3.3 Pruning parameter selection by gap statistic and gene size control
In the meta-analytic framework, pruning step is integrated into the objective function in
order to estimate the parameters and to avoid large non-informative biclusters. Fig. 4.2
compares the performances of bicluster discovery with and without pruning steps. When
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Figure 4.2: Performance of biclustering detection by single-study versus meta-analysis to-
wards noise and sample size. (A) Jaccard similarity over simulation noise without pruning
steps; (B) Jaccard similarity over simulation noise with pruning steps; (C) Jaccard similarity
over sample subset ratio without pruning steps; (D) Jaccard similarity over sample subset
ratio with pruning steps.
the Jaccard accuracy in a large scale when compared to non-pruning analysis(τ1 = τ2 = 0,
Fig. 4.2A). Similarly, in the subsampling analysis, pruning results outperform the non-
pruning ones (Fig. 4.2D over Fig. 4.2C).
When pruning step in Eq. 4.1 was first proposed by [Turner et al., 2005a,b], the param-
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eters ν1 and ν2 were arbitrarily recommended in the paper. Here to provide an automatic
pipeline for pruning parameter selection for (τ1 and τ2) in MetaBiclust, we borrowed the
concept of gap statistic from cluster number selection [Tibshirani et al., 2001]. Fig. 4.3A
compares three settings: red for Jaccard similarity for bicluster detection without pruning
step, green for results with pruning parameters seleceted by gap statistic, and blue the best
performance we can achieve within the searching space. The result shows that gap statistic
can successfully choose the pruning parameters to help increase biclustering performance,
especially when the noise is large. Besides consistent genes, we also simulated consistent +
prevalent genes and consistent + study-specific genes(Fig. C.2 and Fig. C.3). All of them
prove a better perfromance of gap statistic over non-pruning analysis.
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Figure 4.3: Performance of MetaBiclust detection. (A) Performance of bicluster detection
without pruning step (red line), with pruning step where parameters are selected by gap
statistic (green line), and the best performance within the searching space (blue line). (B)
Performance of bicluster detection with strong ( 9% to 11%, red line), week (5% to 15%,
green line), and without gene size control (blue line). The underlying truth of gene selection
rate is 10%.
Alternatively we tried to maximize the log of gap statistic ( max(τ1,τ2) log(Gap(τ1, τ2)) =
log(Enull[obj(τ1, τ2)]) − log(obj(τ1, τ2))). Fig. C.4 shows a very similar result to Fig. 4.3
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for consistent gene simulations. Similarly, Fig. C.5 and Fig. C.6 illustrate the log of
gap statistic performance on consistent + prevalent and consistent + study-specific gene
simulations. With clear evidence that both gap statistic and log of gap statistic lead to
similar performance, we finally decide to implement gap statistic for self-evaluation of pruning
parameters.
It has been reported that gap statistic tends to over-estimate the number of clusters [Yan
and Ye, 2007]. In our situation, the algorithm tends to identify biclusters with very large
gene sets when noise level is high. To rank genes for controlling gene size, we proposed the






. For example, if the gene
size range is set by user to be [50, 200], for each EM iteration step, if the number of selected
genes exceeds 200, only the top 200 genes will be selected based on their gene information
ranking. We simulated true bicluster gene size to be 10% of the total genes. Fig. 4.3B
shows the performance of bicluster detection with strong (9% to 11%, red line), week (5%
to 15%, green line), and without (blue line) gene size control. Correct range of gene size
control will improve the biclsuter detection compared to no control because prior knowledge
is introduced. However, incorrect gene size control will decrease the performance when the
noise is low, but will perform better than no control when the noise is large (Fig. C.7). In
our real data application, since the data signals are often noisy and complex, we decided
to control the gene size to a reasonable range to the best of our knowledge (for example,
between 200 to 500).
4.3.4 Applying bicluster genes selected from multiple training studies to an
independent testing cohort
To evaluate accuracy of applying genes selected from MetaBiclust to an independent testing
cohort, we simulated four studies as before, treated the first three studies as training data
and used the fourth study for independent testing. Firstly, biclusters are discovered from the
three training datasets using MetaBiclust. Genes selected by MetaBiclust are applied to the
testing cohort. When discovering biclusters in the testing cohort, selected genes from training
data are fixed in the EM iterations while only sample selection was performed to minimize
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the objective function. Fig. 4.4 illustrates the training and testing bicluster performance
when given different background noise. The result showed that testing bicluster discovery
only performed slightly worse than the training bicluster detection when the noise level was
low, and very close performance was found for high noise level. It proved that genes selected


























Figure 4.4: Performance evaluation of biclusters detecting from training studies (red line)
and testing studies (green line). Genes from training biclsuter are applied and fixed in testing
bicluster detection.
4.3.5 Breast cancer application
The MetaBiclust pipeline was applied to five breast cancer cohorts using different platforms
(Table 4.1). We set a very large λ value such that biclusters detected from each single study
contained exactly the same gene selection. The number of genes and samples for the detected
biclusters are shown in Table C.2. As expected, the first several biclusters included all the
samples, showing gene modules co-expressed across the whole population. Starting from the
9th bicluster, we were able to obtain biclusters with subset of samples. Taking the 12th bi-
cluster as an example, Fig. C.8 shows the heatmap of the biclusters detected, where each row
represents a selected gene and columns represent the samples. Samples inside the bicluster
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were marked by orange color and otherwise by grey color. Fig C.8 illustrates that biclusters
can successfully divide samples with different expression pattern among a selected subset
of genes. Breast cancer patients are traditionally classified by their estrogen receptor (ER)
status (ER positive or ER negative). With clinical information available for METABRIC,
samples in many biclusters are highly associated with ER status (Table C.3 by Fisher’s exact
test). Currently, breast cancer patients are often classified into five subtypes: Luminal A,
Luminal B, Her2-enriched, Basal and normal-like. For METABRIC cohort, samples inside
the 12th bicluster are more enriched in Her and Basel subtypes (Table C.4) using the PAM50
classification rule [Parker et al., 2009; Tibshirani et al., 2002]. Further, Fig 4.5 and Table
C.3 shows that samples selected by the 12th bicluster has significantly lower survival curve
compared to patients not selected by the bicluster (p=7.13E-11 using log-rank test). Path-
way enrichment analysis is applied to genes selected by each bicluster (from bicluster 9 to
15). Table C.5 lists the number of significantly enriched pathways (or gene sets) under FDR
control at 5%. For the 12th bicluster, top enriched pathways are listed in Table 4.3. In chem-
ical and genetic perturbation (CGP) category, gene lists from many previous breast cancer
experiments have shown extremely high association. In Reactome and Gene Ontology, many
enriched pathways are fundamental cell cycle regulations and chromosomal organization or
helicase activity. Both evaluations on sample and gene selections of detected biclusters in-
dicate that the proposed MetaBiclust pipeline integrates multiple transcriptomic studies to
detect biclusters that form basis to characterize clinically meaningful disease subtypes.
4.4 CONCLUSION AND DISCUSSION
In this paper, we extended the plaid model algorithm to meta-analytic framework aiming
to detect biclusters from multiple cohorts at the same time. With known underlying truth
in synthetic data, meta-analysis can increase the bicluster detection accuracy compared to
single-study analysis, especially when the simulated background noise is large. For data
with small sample size, meta-analysis was also able to beat single-study analysis to detect
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Figure 4.5: Kaplan-Meier survival curves for samples inside (red line) and outside (blue line)
the bicluster of METABRIC cohorts.
Table 4.3: Top significant enriched pathways by the 12th bicluster genes.







CGP SMID BREAST CANCER BASAL UP 3.13E-61 8.11E-58 196 110 16.00
VANTVEER BREAST CANCER ESR1 DN 8.54E-42 1.11E-38 106 68 18.56
BENPORATH PROLIFERATION 5.29E-26 4.57E-23 53 38 23.39
SOTIRIOU BREAST CANCER GRADE 1 VS 3 UP 1.43E-22 9.28E-20 49 34 20.61
ZHOU CELL CYCLE GENES IN IR RESPONSE 24HR 2.64E-22 1.37E-19 44 32 24.08
Reactome REACTOME G2 M CHECKPOINTS 9.40E-08 2.82E-05 11 9 37.46
REACTOME CELL CYCLE 1.56E-07 2.82E-05 86 27 3.98
REACTOME CELL CYCLE MITOTIC 3.03E-07 3.64E-05 68 23 4.41
REACTOME ACTIVATION OF ATR IN RESPONSE
TO REPLICATION STRESS
1.31E-06 1.18E-04 8 7 57.99
REACTOME CELL CYCLE CHECKPOINTS 5.81E-06 4.18E-04 26 12 7.19
GO BP GO CHROMOSOME ORGANIZATION 5.46E-10 1.49E-06 161 45 3.53
GO MITOTIC CELL CYCLE 1.33E-09 1.82E-06 148 42 3.58
GO CELL CYCLE PROCESS 3.94E-09 3.60E-06 194 49 3.09
GO DNA METABOLIC PROCESS 3.42E-08 2.34E-05 112 33 3.69
GO DNA DEPENDENT DNA REPLICATION 6.21E-08 3.40E-05 19 12 14.41
GO CC GO CHROMOSOMAL REGION 2.01E-07 6.69E-05 48 19 5.60
GO CHROMOSOME TELOMERIC REGION 2.00E-06 3.17E-04 24 12 8.39
GO NUCLEAR CHROMOSOME 2.87E-06 3.17E-04 98 27 3.29
GO NUCLEAR CHROMOSOME TELOMERIC REGION 5.46E-06 4.53E-04 22 11 8.36
GO CHROMOSOME 3.71E-05 2.20E-03 148 33 2.49
GO MF GO DNA HELICASE ACTIVITY 5.36E-06 2.50E-03 9 7 28.95
GO DNA DEPENDENT ATPASE ACTIVITY 3.22E-05 7.51E-03 14 8 11.06
GO HELICASE ACTIVITY 2.81E-04 4.38E-02 22 9 5.75
more robust biclusters in multiple studies (Fig. 4.2). We introduced gap statistic method
and controlled the bicluster gene size in order to prune non-informative genes and samples
automatically (Fig. 4.3). The generalizability of the bicluster genes was also proved by
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applying bicluster genes detected from training data into testing data (Fig. 4.4). In real
data application, we discovered biclusters from 5 breast cancer expression datasets (Table
C.5).The results showed that our meta-biclustering algorithm succeeded in detecting genes
enriched in breast cancer and cell cycle related pathways (Table 4.3 and Table C.5) and
samples showing significantly differential survival trend (Fig. 4.5 and Table C.3).
We summarized several key discussions for applying the meta-biclustering pipeline below,
1. Both setting pruning parameters (τ1 and τ2) manually and automatically have their
pros and cons. On one hand, selecting reasonable parameters needs prior knowledge
available; while an arbitrary setting though simple, tend to lose accuracy. On the other
hand, automatic setting by gap statistic permutation is able to improve the performances
without additional information provided, however, it requires larger computing to do
simultaneous search for (τ1, τ2) combinations. In our application, instead of fixing a
large searching space, the algorithm starts by searching along a large interval and then
zoom in gradually to balance the computing cost and searching resolution.
2. In real-data whole-genome application, we suggest to control the gene size to a reasonable
range between 200 to 500 based on the following considerations. Large gene set might
introduce a decent number of non-informative genes; small gene size setting, on the other
hand, might over-penalize the genes and thus miss the main signals.
3. Real data are often noisier and more complex than synthetic data. For this reason, the
algorithm will select all the samples for the first several biclusters in real application. But
after removing these noisy signals, the algorithm is able to discover biclusters successfully
with both reasonable gene and sample sizes for all the studies.
4. Meta term parameter λ will control the consistency of gene selection in multiple studies.
An extremely large λ value can guarantee exactly the same gene set selection, while a
zero setting represents no consistency control. In order to discovery prevalent or study-
specific genes, a reasonable λ value can be set between zero and infinity to control the
penalty (Fig. 4.1 and Fig. C.1).
Some future directions are proposed to improve the algorithm further. (1) Several large
and non-informative biclsuters can be first subtracted from the data matrix in order to
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remove background noise. Then significant biclusters with both reasonable gene and sample
sizes can be detected from the remaining data matrix. (2) The plaid model can also be
extended into vertical meta-analysis direction, that is, simultaneously detecting biclusters
from the same cohort but different types of omics data.
4.5 APPENDIX
To prove that the first objective function is equivalent to the improved pruning step.













































































where I(expr) is the indicator function that equals to one if expr is true, otherwise zero.
Similar to sample partition pruning. As a whole, it proves that the integrated objective
function is equivalent to the improved form of pruning steps.
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5.0 CONCLUSIONS
This dissertation majorly includes three genomic integrative studies to improve the perfor-
mance of fusion transcripts detection from paired-end RNA-seq data, gene three-way liquid 
association analysis, and bicluster discovery.
In chapter 1, we introduced two genomic high-throughput technologies (microarray and 
next generation sequencing) and briefly reviewed fusion transcripts, gene expression and 
regulation, and biclustering algorithms. The work can be divided into two types of integra-
tion. On one hand, multiple tools (or algorithms) have been developed for the same purpose 
while in general no single one can over-perform the others in each evaluation criteria. This 
motivates the idea to combine the results of top performing tools to increase the overall 
performance. Chapter 2 compared 15 fusion transcript detection tools using RNA-seq data 
and developed a meta-caller to combine the results from multiple pipelines. On the other 
hand, taking the advantage of high-throughput genomic data from many public accessible 
database, researchers are able to collect multiple types of omics data from different cohorts 
or platforms. Instead of limited to one single cohort, combining multiple cohorts can in-
crease the stability and produce more generalizable results for future new studies. Chapter 
3 and Chapter 4 aimed to developed meta-analysis pipelines to detect liquid association and 
biclustering from multiple cohorts.
In chapter 2 for the first project, we evaluated 15 tools developed to detect fusion tran-
scripts from paired-end RNA-seq data. Three types of data are used for the comparison: 
in silico synthetic read sequences with known fusions, real data RNA-seq (breast cancer, 
melanoma and prostate cancer) with validated fusion transcripts, and an experimentally 
synthesized data with designed fusions. Tools are evaluated in terms of precision, recall, F-
measure, number of supporting reads and computing time for data with different sequencing
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depth, read length, insert size and background noise. Though we can still rank the overall
performance of these tools, but no single pipeline was able to perform better than the others
in all the criteria. In order to improve the performance, we proposed a meta-caller to com-
bine the results from several top performing pipelines to re-prioritize the candidate fusion
transcripts. Our results showed that the fusion meta-caller can overall improve the balance
between precision and recall rates, and thus provide a better ranked fusion candidate list for
experimental validation.
In chapter 3 for the second project, we extended the liquid association algorithm into two
meta-analytic frameworks: MetaLA for liquid association and MetaMLA for modified liquid
association. Liquid association quantifies the three-way gene regulation where the correlation
between two genes depends on the expression level of a third gene (scouting gene). In order to
improve the performance of liquid association detection, we extend the algorithm to multiple
cohorts to detect more robust and generalizable results. Our methods were applied into five
Yeast datasets treated with different environmental stimuli. Compared to single-analysis,
genes from the top triplets of both the MetaLA and MetaMLA pipelines were enriched
into more significant pathways. Besides, enriched pathways from meta-analysis were more
consistent with each single-study, while there is almost no overlap between pairwise single
studies. In addition, genes from the top triplets can contribute to gene network construction,
where many predicted associations can be validated by known protein-protein interactions.
The results showed the promising future that our MetaLA and MetaMLA pipeline can be
used for three-way gene regulation predictions.
In chapter 4 for the third project, we aimed to detect biclusters from multiple cohorts with
consistent gene selection. Plaid model is one of the most popular biclustering algorithms that
assumes the expression matrix to be the superposition of multiple layers (biclusters), and each
bicluster can be represented as the sum of mean, row (gene) and column (sample) effects. In
order to gain power, we extended this single-study algorithm into meta-analysis framework.
In simulation studies (with known biclusters), compared to single-study analysis, our meta-
biclustering algorithm was able to increase the accuracy especially for large simulation noise
and small sample size. Gap statistic was introduced into the algorithm to estimate pruning
parameters for more informative gene and sample selection. In real data application, our
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algorithm was applied to five breast cancer cohorts. The bicluster genes were highly enriched
into many breast cancer related pathways, and the bicluster sample splitting can group
samples with different survival behaviors. All these results showed that our meta-biclsutering
provides a better method to group genes and samples from multiple cohorts.
As a whole, this dissertation improved the fusion transcript detection, liquid association
analysis and biclustering by the integration of multiple methods or cohorts. These provide
better predictions of the genome structure variation, complex gene regulation pattern, and




SUPPLEMENTARY MATERIAL FOR AIM 1
A.1 SUPPLEMENTARY TABLES
Table A.1: Summary of computational tools published since 2010.
Tools Fusion point Platform Published
MapSplice No restriction Illumina Wang et al. [2010]
Trans-ABySS Canonical splicing pattern Illumina Robertson et al. [2010]
FusionSeq No restriction Illumina/SOLiD Sboner et al. [2010]
ShortFuse No restriction Illumina/SOLiD Kinsella et al. [2011]
Comrad No restriction Illumina McPherson et al. [2011b]
FusionHunter Canonical splicing pattern Illumina Li et al. [2011b]
FusionMap Canonical splicing pattern Illumina Ge et al. [2011]
deFuse No restriction Illumina McPherson et al. [2011a]
SnowShoes-FTD Within exon boundary Illumina Asmann et al. [2011]
chimerascan No restriciton Illumina Iyer et al. [2011]
FusionCatcher No restriction Illumina/SOLiD Nicorici et al. [2014]
TopHat-Fusion No restriction Illumina Kim and Salzberg [2011]
BreakFusion No restriction Illumina Chen et al. [2012]
FusionAnalyser Within exon boundary Illumina Piazza et al. [2012]
LifeScope SOLiD Sakarya et al. [2012]
Bellerophontes No restriction Illumina Abate et al. [2012]
FusionFinder Within exon boundary Illumina Francis et al. [2012]
EricScript Within exon or exon boundary Illumina Benelli et al. [2012]
SOAPfuse No restriction Illumina Jia et al. [2013]
FusionQ No restriction Illumina/SOLiD Liu et al. [2013]
SOAPfusion Within exon or exon boundary Illumina Wu et al. [2013]
PRADA Within exon boundary Illumina Torres-Garc´ıa et al. [2014]
JAFFA Within exon or exon boundary Illumina Davidson et al. [2015]
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Table A.2: Description of fifteen fusion detection tools and their default (or available)
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Table A.3: 150 designed fusions in the synthetic data.
Gene1ID Gene2ID Gene1Name Gene2Name
ENSG00000008282 ENSG00000075790 SYPL1 BCAP29
ENSG00000011405 ENSG00000244165 PIK3C2A P2RY11
ENSG00000022556 ENSG00000100504 NLRP2 PYGL
ENSG00000028310 ENSG00000173273 BRD9 TNKS
ENSG00000055609 ENSG00000100364 MLL3 KIAA0930
ENSG00000062038 ENSG00000044115 CDH3 CTNNA1
ENSG00000069493 ENSG00000102024 CLEC2D PLS3
ENSG00000070501 ENSG00000196873 POLB CBWD3
ENSG00000072041 ENSG00000182944 SLC6A15 EWSR1
ENSG00000077549 ENSG00000143549 CAPZB TPM3
ENSG00000084710 ENSG00000026103 EFR3B FAS
ENSG00000095539 ENSG00000181090 SEMA4G EHMT1
ENSG00000100239 ENSG00000105810 PPP6R2 CDK6
ENSG00000100744 ENSG00000142541 C14orf129 RPL13A
ENSG00000101138 ENSG00000115946 CSTF1 PNO1
ENSG00000101945 ENSG00000116703 SUV39H1 PDC
ENSG00000105568 ENSG00000126070 PPP2R1A EIF2C3
ENSG00000106991 ENSG00000105856 ENG HBP1
ENSG00000109072 ENSG00000139372 SEBOX TDG
ENSG00000110786 ENSG00000146013 PTPN5 GFRA3
ENSG00000112414 ENSG00000100276 GPR126 RASL10A
ENSG00000114120 ENSG00000171307 SLC25A36 ZDHHC16
ENSG00000114626 ENSG00000169439 ABTB1 SDC2
ENSG00000115392 ENSG00000173614 FANCL NMNAT1
ENSG00000115935 ENSG00000163430 WIPF1 FSTL1
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ENSG00000115966 ENSG00000115446 ATF2 UNC50
ENSG00000116809 ENSG00000140577 ZBTB17 CRTC3
ENSG00000118557 ENSG00000051382 PMFBP1 PIK3CB
ENSG00000119139 ENSG00000188554 TJP2 NBR1
ENSG00000119772 ENSG00000130640 DNMT3A TUBGCP2
ENSG00000121577 ENSG00000205981 POPDC2 DNAJC19
ENSG00000124596 ENSG00000198363 C6orf130 ASPH
ENSG00000125122 ENSG00000186231 LRRC29 KLHL32
ENSG00000125630 ENSG00000119535 POLR1B CSF3R
ENSG00000128512 ENSG00000186952 DOCK4 TMEM232
ENSG00000130038 ENSG00000150527 EFCAB4B CTAGE5
ENSG00000130844 ENSG00000104325 ZNF331 DECR1
ENSG00000132321 ENSG00000170236 IQCA1 USP50
ENSG00000132323 ENSG00000173715 ILKAP C11orf80
ENSG00000134375 ENSG00000140854 TIMM17A KATNB1
ENSG00000135269 ENSG00000134940 TES ACRV1
ENSG00000136541 ENSG00000048740 ERMN CELF2
ENSG00000136546 ENSG00000171109 SCN7A MFN1
ENSG00000137404 ENSG00000184708 NRM EIF4ENIF1
ENSG00000142494 ENSG00000164941 SLC47A1 INTS8
ENSG00000146263 ENSG00000158552 MMS22L ZFAND2B
ENSG00000146909 ENSG00000174236 NOM1 REP15
ENSG00000147044 ENSG00000185305 CASK ARL15
ENSG00000148296 ENSG00000123700 SURF6 KCNJ2
ENSG00000151726 ENSG00000012048 ACSL1 BRCA1
ENSG00000154556 ENSG00000143774 SORBS2 GUK1
ENSG00000156502 ENSG00000106686 SUPV3L1 SPATA6L
ENSG00000157600 ENSG00000108961 TMEM164 RANGRF
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ENSG00000157601 ENSG00000124181 MX1 PLCG1
ENSG00000158055 ENSG00000160310 GRHL3 PRMT2
ENSG00000161835 ENSG00000165138 GRASP ANKS6
ENSG00000162174 ENSG00000104936 ASRGL1 DMPK
ENSG00000163281 ENSG00000164896 GNPDA2 FASTK
ENSG00000165219 ENSG00000148660 GAPVD1 CAMK2G
ENSG00000165275 ENSG00000153029 TRMT10B MR1
ENSG00000165802 ENSG00000137207 NELF YIPF3
ENSG00000166333 ENSG00000129219 ILK PLD2
ENSG00000167822 ENSG00000164032 OR8J3 H2AFZ
ENSG00000168000 ENSG00000141564 BSCL2 RPTOR
ENSG00000168214 ENSG00000149571 RBPJ KIRREL3
ENSG00000170525 ENSG00000188859 PFKFB3 FAM78B
ENSG00000171055 ENSG00000183474 FEZ2 GTF2H2C
ENSG00000172939 ENSG00000169239 OXSR1 CA5B
ENSG00000173482 ENSG00000156990 PTPRM RPUSD3
ENSG00000173638 ENSG00000139233 SLC19A1 LLPH
ENSG00000175691 ENSG00000120910 ZNF77 PPP3CC
ENSG00000178882 ENSG00000165799 FAM101A RNASE7
ENSG00000186431 ENSG00000048828 FCAR FAM120A
ENSG00000186523 ENSG00000154429 FAM86B1 CCSAP
ENSG00000188493 ENSG00000182934 C19orf54 SRPR
ENSG00000196104 ENSG00000185627 SPOCK3 PSMD13
ENSG00000203685 ENSG00000148426 C1orf95 C10orf47
ENSG00000205327 ENSG00000256061 OR6C68 DYX1C1
ENSG00000215454 ENSG00000100918 KRTAP10-4 REC8
ENSG00000255501 ENSG00000001084 CARD18 GCLC
ENSG00000007264 ENSG00000122642 MATK FKBP9
101
ENSG00000007350 ENSG00000137501 TKTL1 SYTL2
ENSG00000011347 ENSG00000136247 SYT7 ZDHHC4
ENSG00000015133 ENSG00000205583 CCDC88C STAG3L1
ENSG00000037474 ENSG00000189308 NSUN2 LIN54
ENSG00000065150 ENSG00000110077 IPO5 MS4A6A
ENSG00000074319 ENSG00000082516 TSG101 GEMIN5
ENSG00000078618 ENSG00000076554 NRD1 TPD52
ENSG00000085377 ENSG00000196642 PREP RABL6
ENSG00000087460 ENSG00000140299 GNAS BNIP2
ENSG00000092421 ENSG00000167173 SEMA6A C15orf39
ENSG00000102125 ENSG00000049618 TAZ ARID1B
ENSG00000102243 ENSG00000102271 VGLL1 KLHL4
ENSG00000103363 ENSG00000172366 TCEB2 FAM195A
ENSG00000103591 ENSG00000075426 AAGAB FOSL2
ENSG00000109339 ENSG00000179698 MAPK10 KIAA1875
ENSG00000111271 ENSG00000174175 ACAD10 SELP
ENSG00000112624 ENSG00000107438 KIAA0240 PDLIM1
ENSG00000116254 ENSG00000083454 CHD5 P2RX5
ENSG00000116761 ENSG00000116830 CTH TTF2
ENSG00000118729 ENSG00000113312 CASQ2 TTC1
ENSG00000118997 ENSG00000151779 DNAH7 NBAS
ENSG00000119042 ENSG00000137948 SATB2 BRDT
ENSG00000119844 ENSG00000152413 AFTPH HOMER1
ENSG00000119986 ENSG00000115685 AVPI1 PPP1R7
ENSG00000122145 ENSG00000127993 TBX22 RBM48
ENSG00000122741 ENSG00000102359 DCAF10 SRPX2
ENSG00000123552 ENSG00000106078 USP45 COBL
ENSG00000126107 ENSG00000013288 HECTD3 MAN2B2
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ENSG00000130787 ENSG00000002726 HIP1R ABP1
ENSG00000133026 ENSG00000163328 MYH10 GPR155
ENSG00000133985 ENSG00000181135 TTC9 ZNF707
ENSG00000134324 ENSG00000088305 LPIN1 DNMT3B
ENSG00000134343 ENSG00000101158 ANO3 TH1L
ENSG00000134627 ENSG00000204580 PIWIL4 DDR1
ENSG00000137070 ENSG00000088298 IL11RA EDEM2
ENSG00000138069 ENSG00000144908 RAB1A ALDH1L1
ENSG00000138386 ENSG00000158639 NAB1 PAGE5
ENSG00000138395 ENSG00000123130 CDK15 ACOT9
ENSG00000140285 ENSG00000100353 FGF7 EIF3D
ENSG00000144820 ENSG00000108292 GPR128 MLLT6
ENSG00000146828 ENSG00000168275 SLC12A9 C1orf31
ENSG00000147133 ENSG00000127989 TAF1 MTERF
ENSG00000149636 ENSG00000134453 DSN1 RBM17
ENSG00000150477 ENSG00000075914 KIAA1328 EXOSC7
ENSG00000150995 ENSG00000142920 ITPR1 ADC
ENSG00000151136 ENSG00000177106 BTBD11 EPS8L2
ENSG00000154134 ENSG00000131503 ROBO3 ANKHD1
ENSG00000160867 ENSG00000134986 FGFR4 NREP
ENSG00000162909 ENSG00000168569 CAPN2 TMEM223
ENSG00000163541 ENSG00000163166 SUCLG1 IWS1
ENSG00000168509 ENSG00000102158 HFE2 MAGT1
ENSG00000169230 ENSG00000158517 PRELID1 NCF1
ENSG00000169914 ENSG00000173077 OTUD3 1-Dec
ENSG00000170166 ENSG00000092203 HOXD4 TOX4
ENSG00000172007 ENSG00000141540 RAB33B TTYH2
ENSG00000174899 ENSG00000139182 C3orf55 CLSTN3
103
ENSG00000176641 ENSG00000148985 RNF152 PGAP2
ENSG00000177311 ENSG00000164129 ZBTB38 NPY5R
ENSG00000183963 ENSG00000153237 SMTN CCDC148
ENSG00000184497 ENSG00000099204 FAM70B ABLIM1
ENSG00000185189 ENSG00000239713 NRBP2 APOBEC3G
ENSG00000185303 ENSG00000125676 SFTPA2 THOC2
ENSG00000188282 ENSG00000162191 RUFY4 UBXN1
ENSG00000188343 ENSG00000104824 FAM92A1 HNRNPL
ENSG00000189157 ENSG00000073417 FAM47E PDE8A
ENSG00000197561 ENSG00000125944 ELANE HNRNPR
ENSG00000198130 ENSG00000166428 HIBCH PLD4
ENSG00000205726 ENSG00000188130 ITSN1 MAPK12
ENSG00000239857 ENSG00000180822 GET4 PSMG4
Table A.4: The read numbers of type-1A and type-1B synthetic datasets.
Coverage 50 bp 75 bp 100 bp
5X 16,832 11,221 8,416
20X 67,328 44,885 33,664
50X 168,320 112,213 84,160
100X 336,641 224,427 168,320
200X 673,282 448,854 336,641
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Table A.5: Read numbers for type-2, type-3A and type-3B synthetic datasets.
Type Composition 50 bp 75 bp 100 bp
Type-2 Background data 2,000,000 2,000,000 2,000,000
Type-3A Synthetic data 336,641 224,426 168,284
Type-3B Synthetic + Background data 2,336,641 2,224,426 2,168,284
Table A.6: Insert sizes for type-2, type-3A and type-3B synthetic datasets.
Tissue SRA ID Insert size mean value Insert size SD value
Lung SRR349695 164 bp 48 bp
Parathyroid SRR479053 192 bp 85 bp
Skeletal myocyte SRR1693845 353 bp 116 bp
Bladder SRR400342 248 bp 26 bp
T cell SRR1909130 290 bp 120 bp
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Read number Validated fusions
Breast BT474 50 180 ± 80 21,423,697
ACACA - STAC2, RPS6KB1 - SNF8,
VAPB - IKZF3, ZMYND8 - CEP250,
RAB22A - MYO9B, SKA2 - MYO19,
DIDO1 - KIAA0406, STARD3 - DOK5,
LAMP1 - MCF2L, GLB1 - CMTM7, CPNE1 - PI3
Cancer KPL4 50 180 ± 80 6,796,443 BSG - NFIX, PPP1R12A - SEPT10,
NOTCH1 - NUP214
MCF7 50 180 ± 80 8,409,785 BCAS4 - BCAS3, ARFGEF2 - SULF2,
PRPS6KB1 - TMEM49
SKBR3 50 180 ± 80 18,140,246
TATDN1 - GSDMB, CSE1L - ENSG00000236127,
RARA - PKIA, ANKHD1 - PCDH1,
CCDC85C - SETD3, SUMF1 - LRRFIP2,
WDR67 - ZNF704, CYTH1 - EIF3H,
DHX35 - ITCH, NFS1 - PREX1
Melanoma 501Mel 50 351± 139 14,857,046 CCT3 - C1orf61, GNA12 - SHANK2,
SLC12A7 - C11orf67, PARP1 - MIXL1
M000216 50 393± 115 13,868,165 KCTD2 - ARHGEF12
M000921 50 627± 564 14,468,771 TMEM8B - TLN1, RECK - ALX3
M010403 50 374 ± 159 8,168,750 SCAMP2 - WDR72
M980409 50 334 ± 119 15,768,555 GCN1L1 - PLA2G1B
M990802 50 355 ± 125 16,066,999 ANKHD1 - C5orf32, RB1 - ITM2B
Prostate 158T 100 140 ± 27 221,206,388 SLC45A3 - ELK4, MTOR - TP53BP1
Cancer 159T 100 153 ± 33 159,766,465 TRMT11 - GRIK2, MAN2A1 - FER,
KDM4B - AC011523.2, CCNH - C5orf30
165T 100 158 ± 40 243,191,643 SLC45A3 - ELK4, TMEM135 - CCDC67
171T 100 143 ± 30 118,742,381 TMPRSS2 - ERG
49T 100 158 ± 37 250,071,864 SLC45A3 - ELK4, TMPRSS2 - ERG,
LRRC59 - SLC22A10
Table A.8: Parameter setting for TopHat-Fusion.
Options Explanation
–no-coverage-search Disable the coverage based search for junctions
–fusion-min-dist 1000000 Default minimum distance
–fusion-ignore-chromosomes chrM Ignore chromosome M
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Table A.9: Parameter setting for anchor length and spanning/split reads of all the fifteen
tools.






MapSplice - - -
User self-filter for spanning
+split as 4
ShortFuse - - -
A score to rank the
detected fusion transcripts








deFuse 10 3 1
chimerascan 10 - -
Set spanning+split as 4;
maximum mismatch is 3
FusionCatcher 10 3 1
TopHat-Fusion 10 3 1
BreakFusion - - -
User self-filter for spanning
+split as 4
EricScript - - -
User self-filter for spanning
/split read on the output
SOAPfuse 10 3 1
FusionQ 10 3 1
PRADA - - -
User self-filter for spanning
+split as 4
SnowShoes-FTD - - -
Set spanning
+split as 4
JAFFA - 3 1
User self-filter for spanning
/split read on the output
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FusionHunter failed failed failed Y Y Y Y
Stack smashing
for synthetic data
FusionMap Y Y Y Y Y Y




chimerascan Y Y Y Y Y Y Y
FusionCatcher Y Y Y Y Y Y Y




BreakFusion Y Y Y Y Y Y Y
Ericscript Y Y Y Y Y 0 output Y
SOAPfuse Y Y Y Y Y Y Y










PRADA Y Y Y Y Y Y Y
SnowShoes
-FTD




JAFFA Y Y Y Y Y Y Y







Table A.12: The summary of the recall rates, precision rates and F-measures for type-1A
with read 100 bp & 100X.
Detection tools TP FP FN TP+FP Recall Precision F-measure
SOAPfuse 139 26 11 165 0.927 0.842 0.882
FusionCatcher 108 20 42 128 0.72 0.844 0.777
JAFFA 88 16 62 104 0.587 0.846 0.693
EricScript 104 13 46 117 0.693 0.889 0.779
chimerascan 105 30 45 135 0.7 0.778 0.737
PRADA 57 2 93 59 0.38 0.966 0.545
deFuse 73 9 77 82 0.487 0.89 0.63
FusionMap 92 27 58 119 0.613 0.773 0.684
TopHat-Fusion 53 14 97 67 0.353 0.791 0.488
MapSplice 51 8 99 59 0.34 0.864 0.488
BreakFusion 106 44 44 150 0.707 0.707 0.707
SnowShoes-FTD 3 1 147 4 0.02 0.75 0.039
FusionQ 81 18 69 99 0.54 0.818 0.651
FusionHunter - - - - - - -
ShortFuse - - - - - - -
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Table A.13: The summary of the recall rates, precision rates and F-measures for type-1B
with read 100 bp & 100X.
Detection tools TP FP FN TP+FP Recall Precision F-measure
SOAPfuse 136 22 14 158 0.907 0.861 0.883
FusionCatcher 110 18 40 128 0.733 0.859 0.791
JAFFA 86 20 64 106 0.573 0.811 0.672
EricScript 111 15 39 126 0.74 0.881 0.804
chimerascan 96 26 54 122 0.64 0.787 0.706
PRADA 57 3 93 60 0.38 0.95 0.543
deFuse 123 15 27 138 0.82 0.891 0.854
FusionMap 95 22 55 117 0.633 0.812 0.711
TopHat-Fusion 64 16 86 80 0.427 0.8 0.557
MapSplice 53 9 97 62 0.353 0.855 0.5
BreakFusion 74 36 76 110 0.493 0.673 0.569
SnowShoes-FTD 3 1 147 4 0.02 0.75 0.039
FusionQ 51 12 99 63 0.34 0.81 0.479
FusionHunter - - - - - - -
ShortFuse - - - - - - -
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Table A.14: The summary of the recall rates, precision rates and F-measures for type-3B
lung sample with read 50 bp & 100X.
Detection tools TP FP FN TP+FP Recall Precision F-measure
SOAPfuse 138 27 12 165 0.92 0.836 0.876
FusionCatcher 102 19 48 121 0.68 0.843 0.753
JAFFA 88 12 62 100 0.587 0.88 0.704
EricScript 105 15 45 120 0.7 0.875 0.778
chimerascan 91 25 59 116 0.607 0.784 0.684
PRADA 55 2 95 57 0.367 0.965 0.532
deFuse 43 7 107 50 0.287 0.86 0.43
FusionMap 72 11 78 83 0.48 0.867 0.618
TopHat-Fusion 66 19 84 85 0.44 0.776 0.562
MapSplice 55 9 95 64 0.367 0.859 0.514
BreakFusion 114 141 36 255 0.76 0.447 0.563
SnowShoes-FTD 3 1 147 4 0.02 0.75 0.039
FusionQ 37 37 113 74 0.247 0.5 0.331
FusionHunter - - - - - - -
ShortFuse - - - - - - -
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Table A.15: The correlation between five normal tissues by the F-measure of the fifteen
tools on the type-3B dataset.
Lung Parathyroid Bladder Skeletal myocyte T cell
Lung 1 0.95 0.78 0.94 0.92
Parathyroid - 1 0.79 0.99 0.79
Bladder - - 1 0.87 0.56
Skeletal myocyte - - - 1 0.76
T cell - - - - 1
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Table A.16: The summary of the recall rates, precision rates and F-measures for breast
cancer data.
Detection tools TP FP FN TP+FP Recall Precision F-measure
SOAPfuse 20 48 7 68 0.741 0.294 0.421
FusionCatcher 19 48 8 67 0.704 0.284 0.405
JAFFA 16 16 11 32 0.593 0.5 0.543
EricScript 16 67 11 83 0.593 0.193 0.291
chimerascan 19 96 8 115 0.704 0.165 0.267
PRADA 15 22 12 37 0.556 0.405 0.469
deFuse 19 116 8 135 0.704 0.141 0.235
FusionMap 6 126 21 132 0.222 0.045 0.075
TopHat-Fusion 15 58 12 73 0.556 0.205 0.3
MapSplice 16 37 11 53 0.593 0.302 0.4
BreakFusion 15 1923 12 1938 0.556 0.008 0.016
SnowShoes-FTD 15 5 12 20 0.556 0.75 0.639
FusionQ 4 453 23 457 0.148 0.009 0.017
FusionHunter 13 10 14 23 0.481 0.565 0.52
ShortFuse 19 24 8 43 0.704 0.442 0.543
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Table A.17: The summary of the recall rates, precision rates and F-measures for melanoma
data.
Detection tools TP FP FN TP+FP Recall Precision F-measure
SOAPfuse 10 98 1 108 0.909 0.093 0.169
FusionCatcher 3 6 8 9 0.273 0.333 0.3
JAFFA 2 2 9 4 0.182 0.5 0.267
EricScript 3 67 8 70 0.273 0.043 0.074
chimerascan 5 189 6 194 0.455 0.026 0.049
PRADA 3 4 8 7 0.273 0.429 0.334
deFuse 10 189 1 199 0.909 0.05 0.095
FusionMap 2 85 9 87 0.182 0.023 0.041
TopHat-Fusion 4 25 7 29 0.364 0.138 0.2
MapSplice 5 39 6 44 0.455 0.114 0.182
BreakFusion 6 3092 5 3098 0.545 0.002 0.004
SnowShoes-FTD 4 1 7 5 0.364 0.8 0.5
FusionQ - - - - - - -
FusionHunter 4 4 7 8 0.364 0.5 0.421
ShortFuse 7 30 4 37 0.636 0.189 0.291
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Table A.18: The summary of the recall rates, precision rates and F-measures for prostate
cancer data.
Detection tools TP FP FN TP+FP Recall Precision F-measure
SOAPfuse 7 75 5 82 0.583 0.085 0.148
FusionCatcher 11 82 1 93 0.917 0.118 0.209
JAFFA 6 1815 6 1821 0.5 0.003 0.006
EricScript 11 3798 1 3809 0.917 0.003 0.006
chimerascan 8 1665 4 1673 0.667 0.005 0.01
PRADA 0 13 12 13 0 0 0
deFuse - - - - - - -
FusionMap 7 3759 5 3766 0.583 0.002 0.004
TopHat-Fusion 0 61 12 61 0 0 0
MapSplice 0 4 12 4 0 0 0
BreakFusion 1 3764 11 3765 0.083 0 0
SnowShoes-FTD 5 6 7 11 0.417 0.455 0.435
FusionQ - - - - - - -
FusionHunter 0 5 12 5 0 0 0
ShortFuse - - - - - - -
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Table A.19: The summary of the recall rates, precision rates and F-measures for validation
dataset.
Detection tools TP FP FN TP+FP Recall Precision F-measure
SOAPfuse 4 9 5 13 0.444 0.308 0.364
FusionCatcher 6 17 3 23 0.667 0.261 0.375
JAFFA 5 8 4 13 0.556 0.385 0.455
EricScript 5 358 4 363 0.556 0.014 0.027
chimerascan 6 127 3 133 0.667 0.045 0.084
PRADA 3 4 6 7 0.333 0.429 0.375
deFuse 0 0 0 0 0 0 0
FusionMap 6 324 3 330 0.667 0.018 0.035
TopHat-Fusion 1 5 8 6 0.111 0.167 0.133
MapSplice 4 8 5 12 0.444 0.333 0.381
BreakFusion 2 142 7 144 0.222 0.014 0.026
SnowShoes-FTD 4 3 5 7 0.444 0.571 0.5
FusionQ 0 0 0 0 0 0 0
FusionHunter 2 4 7 6 0.222 0.333 0.266



























































































































































































































































































































Figure A.1: Fuison transcript detection results for type-1A synthetic datasets. The y-axis
bars show the number of true detected positives, among them IE-type and BE-type fusions
are shown in solid and slashed rectangles. The total numbers of fusion detections are shown













































































































































































































































































































































































































































































































Figure A.2: Precision, recall and F-measure for type-1A synthetic data. Results for read
































































































































































































































































































Figure A.3: Fuison transcript detection results for type-1B synthetic datasets. The y-axis
bars show the number of true detected positives, among them IE-type and BE-type fusions
are shown in solid and slashed rectangles. The total numbers of fusion detections are shown














































































































































































































































































































































































































































































































Figure A.4: Precision, recall and F-measure for type-1B synthetic data. Results for read































































































































































Figure A.5: Fusion transcript detection results for type-2, type-3A and type-3B (lung
sample) synthetic datasets on lung sample. The y-axis bars show the number of true detected
positives, among them IE-type and BE-type fusions are shown in solid and slashed rectangles.
The total numbers of fusion detections are shown on top of the bars. (A) results for read





















































































































































































































































































































Figure A.6: Precision, recall and F-measure for type-3B (lung sample) synthetic data.












































































































































































































































































































































Figure A.7: Fuison transcript detection results for type-2, type-3A and type-3B (lung
sample) synthetic datasets on (A) Parathyroid sample (B) Skeletal myocyte sample (C)
Bladder sample and (D) T cell sample for read length 50 bp. The y-axis bars show the
number of true detected positives, among them IE-type and BE-type fusions are shown in
solid and slashed rectangles. The total numbers of fusion detections are shown on top of the
bars.
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Parathyroid	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  myocyte	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Bladder	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   T	  cell	  sample	  
Figure A.8: F-measure for type-3B synthetic data on (A) Parathyroid sample (B) Skeletal
myocyte sample (C) Bladder sample and (D) T cell sample. Results for read 50 bp are
marked as red star.
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Figure A.9: Distribution plots for alignment performance and similarity across tools for
type-1A synthetic data with 50 and 75 bp read length & 100X. Number of true positives
(y-axis) with detected supporting reads greater than the threshold on the x-axis. (A-C)
results for read 50 bp. (D-F) results for read 75 bp. (A) and (D): results for all 150 true
fusion transcripts. (B) and (E): results for only IE-type fusion transcripts. (C) and (F):
results for only BE-type fusion transcripts.
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Figure A.10: Multi-dimensional scaling (MDS) plots to demonstrate pairwise similarity of
detection results from 14 tools and the underlying truth. (A-C) results for read 50 bp. (D-
F) results for read 75 bp. (A) and (D): results for all 150 true fusion transcripts. (B) and
(E): results for only IE-type fusion transcripts. (C) and (F): results for only BE-type fusion
transcripts.
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A	   B	  Type-­‐1A,	  50	  bp	   Type-­‐1A,	  75	  bp	  
C	   D	  Type-­‐1B,	  50	  bp	   Type-­‐1B,	  75	  bp	  
E	   F	  Type-­‐3B,	  75	  bp	   Type-­‐3B,	  100	  bp	  












































































































SOAPfuse FusionCatcher JAFFA Meta−caller
Figure A.11: Precision-recall curves of top 3 performing tools and meta-caller. (A)-(B)
Type-1A synthetic data with read length 50 and 75 bp. (C)-(D) Type-1B synthetic data
with read length 50 and 75 bp. (E)-(F) Type-3B synthetic data (lung sample) with read
length 75 and 100 bp.
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A	   B	  Type-­‐1A,	  100	  bp	   Type-­‐1B,	  100	  bp	  
C	   D	  Type-­‐3B,	  50	  bp	   Breast	  cancer	  
E	   F	  Melanoma	   Prostate	  cancer	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Figure A.12: Precision-recall curves of top 6 performing tools and meta-caller. (A)-(C):
Type-1A, type-1B and type-3B (lung sample) synthetic data with 100X coverage and 100, 100
and 50 bp read length respectively. (D)-(F): Three real datasets: breast cancer, melanoma
and prostate cancer.
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EricScript chimerascan PRADA Meta−caller
SOAPfuse FusionCatcher JAFFA
EricScript chimerascan PRADA Meta−caller
Figure A.13: Precision-recall curves of top-6 performing tools and meta-caller (with majority
vote=3) on validation data.
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APPENDIX B
SUPPLEMENTARY MATERIAL FOR AIM 2
B.1 SUPPLEMENTARY TABLES
Table B.1: The 2 by 2 table for the top m triplets selected by the full analysis. c11: inside
the top m triplets selected by the full analysis, the number of remaining triplets after the
filtering; c12: inside the top m triplets selected by the full analysis, the number of filtered out
triplets; c21: outside the top m triplets selected by the full analysis, the number of remaining
triplets after the filtering; c22: outside the top m triplets selected by the full analysis, the
number of filtered out triplets.
m c11 c12 c21 c22 P -value Odds ratio
2000 1911 89 12,140,346 910,497,294 < 10−200 1610
4000 3781 219 12,138,476 910,497,164 < 10−200 1295
6000 5625 375 12,136,632 910,497,008 < 10−200 1125
8000 7480 520 12,134,777 910,496,863 < 10−200 1079
10000 9310 690 12,132,947 910,496,693 < 10−200 1013
130
Table B.2: Enriched TF binding gene sets for genes controlled by Hog1 from top 100000
triplets selected by meta MLA method.
TF gene P -value q-value Count Size
Hot1 7.67E-06 4.62E-04 10 63
YPR015C 1.057E-05 4.62E-04 13 111
Hog1p 1.44E-05 4.62E-04 17 187
YGR067C 1.50E-03 3.61E-02 12 159
131
Table B.3: Enriched GO terms for all the genes from top 500 triplets selected by meta MLA.
ID P-value q-value Odds ratio Count Size Category Term
GO:0055114 2.08E-17 2.90E-14 3.33 95 327 BP oxidation-reduction process
GO:0016491 3.28E-12 2.29E-09 2.90 77 285 MF oxidoreductase activity
GO:0005739 1.69E-08 7.87E-06 1.69 198 1161 CC mitochondrion
GO:0006412 2.81E-07 9.82E-05 2.29 62 273 BP translation
GO:0005758 1.95E-06 0.000531 4.34 21 58 CC mitochondrial intermembrane space
GO:0009060 2.28E-06 0.000531 5.06 18 49 BP aerobic respiration
GO:0045454 3.15E-06 0.000562 6.16 15 33 BP cell redox homeostasis
GO:0034599 3.22E-06 0.000562 3.44 26 78 BP cellular response to oxidative stress
GO:0005737 4.20E-06 0.000568 1.44 338 2271 CC cytoplasm
GO:0003824 4.40E-06 0.000568 1.98 69 362 MF catalytic activity
GO:0005783 4.81E-06 0.000568 1.80 92 447 CC endoplasmic reticulum
GO:0009055 5.15E-06 0.000568 8.20 12 33 MF electron carrier activity
GO:1902600 5.28E-06 0.000568 9.65 11 28 BP hydrogen ion transmembrane transport
GO:0009277 1.23E-05 0.001224 3.31 24 85 CC fungal-type cell wall
GO:0002181 1.62E-05 0.001508 2.50 36 168 BP cytoplasmic translation
GO:0070469 1.74E-05 0.001519 16.32 8 16 CC respiratory chain
GO:0006730 2.25E-05 0.001852 11.03 9 15 BP one-carbon metabolic process
GO:0000324 2.96E-05 0.002200 2.66 30 106 CC fungal-type vacuole
GO:0005751 3.10E-05 0.002200 21.40 7 12 CC mitochondrial respiratory chain complex IV
GO:0005576 3.15E-05 0.002200 2.98 25 105 CC extracellular region
GO:0071555 3.49E-05 0.002326 2.88 26 93 BP cell wall organization
GO:0005618 4.21E-05 0.002672 3.43 20 68 CC cell wall
GO:0006164 4.57E-05 0.002692 7.66 10 18 BP purine nucleotide biosynthetic process
GO:0008152 4.62E-05 0.002692 1.74 79 463 BP metabolic process
GO:0008121 4.89E-05 0.002735 36.64 6 9 MF ubiquinol-cytochrome-c reductase activity
GO:0030170 7.22E-05 0.003881 4.20 15 41 MF pyridoxal phosphate binding
GO:0031505 8.12E-05 0.004203 2.76 25 88 BP fungal-type cell wall organization
GO:0003735 8.95E-05 0.004471 2.03 46 231 MF structural constituent of ribosome
GO:0006696 0.000114 0.005485 5.62 11 24 BP ergosterol biosynthetic process
GO:0005840 0.000136 0.006357 1.82 59 300 CC ribosome
GO:0005198 0.000147 0.006631 3.84 15 44 MF structural molecule activity
GO:0005750 0.000172 0.007077 18.32 6 10 CC mitochondrial respiratory chain complex III
GO:0006122 0.000172 0.007077 18.32 6 11 BP mitochondrial electron transport, ubiquinol to cytochrome c
GO:0006123 0.000172 0.007077 18.32 6 12 BP mitochondrial electron transport, cytochrome c to oxygen
GO:0020037 0.000183 0.007316 6.89 9 24 MF heme binding
GO:0004129 0.000219 0.008490 10.69 7 19 MF cytochrome-c oxidase activity
GO:0000221 0.000299 0.011287 30.49 5 8 CC vacuolar proton-transporting V-type ATPase, V1 domain
GO:0006457 0.000341 0.012537 2.51 24 91 BP protein folding
GO:0005789 0.000416 0.014927 1.67 67 343 CC endoplasmic reticulum membrane
GO:0005199 0.000461 0.015710 8.55 7 16 MF structural constituent of cell wall
GO:0051015 0.000461 0.015710 8.55 7 12 MF actin filament binding
GO:0030479 0.000585 0.019460 2.84 18 59 CC actin cortical patch
GO:0005886 0.000627 0.020376 1.58 78 446 CC plasma membrane
GO:0016874 0.000701 0.021772 2.07 32 137 MF ligase activity
GO:0015035 0.000701 0.021772 6.11 8 17 MF protein disulfide oxidoreductase activity
GO:0006749 0.000877 0.026082 7.13 7 13 BP glutathione metabolic process
GO:0015991 0.000877 0.026082 7.13 7 16 BP ATP hydrolysis coupled proton transport
GO:0016021 0.000913 0.026604 1.34 193 1324 CC integral component of membrane
GO:0019752 0.001000 0.028535 9.15 6 11 BP carboxylic acid metabolic process
GO:0046961 0.001161 0.032460 5.43 8 19 MF proton-transporting ATPase activity, rotational mechanism
GO:0006888 0.001247 0.033519 2.40 21 80 BP ER to Golgi vesicle-mediated transport
GO:0022625 0.001247 0.033519 2.40 21 99 CC cytosolic large ribosomal subunit
GO:0030134 0.001301 0.034330 4.59 9 22 CC ER to Golgi transport vesicle
GO:0016829 0.001493 0.038657 2.30 22 98 MF lyase activity
GO:0006418 0.001638 0.040880 3.34 12 35 BP tRNA aminoacylation for protein translation
GO:0006950 0.001638 0.040880 3.34 12 43 BP response to stress
GO:0008652 0.001745 0.041051 2.22 23 99 BP cellular amino acid biosynthetic process
GO:0006555 0.001775 0.041051 24.36 4 7 BP methionine metabolic process
GO:0008177 0.001775 0.041051 24.36 4 6 MF succinate dehydrogenase (ubiquinone) activity
GO:0009088 0.001775 0.041051 24.36 4 6 BP threonine biosynthetic process
GO:0006520 0.001833 0.041051 4.89 8 24 BP cellular amino acid metabolic process
GO:0006099 0.001897 0.041051 3.83 10 29 BP tricarboxylic acid cycle
GO:0003779 0.001927 0.041051 3.07 13 41 MF actin binding
GO:0005506 0.001930 0.041051 4.23 9 30 MF iron ion binding
GO:0004601 0.001938 0.041051 7.32 6 11 MF peroxidase activity
GO:0006090 0.001938 0.041051 7.32 6 11 BP pyruvate metabolic process
GO:0051082 0.002154 0.044721 2.32 20 81 MF unfolded protein binding
GO:0005385 0.002175 0.044721 10.16 5 8 MF zinc ion transmembrane transporter activity
132
Table B.4: Pearson correlations of some important genes in each single study.
Gene A Gene B Causton Gasch Rosetta GSE60613 GSE11452
IDH2 CDC19 0.22 -0.09 0.04 0.08 -0.32
IDH2 BDH2 0.41 0.41 -0.07 -0.31 0.10
IDH2 ENO2 -0.02 0.30 -0.04 0.21 -0.36
IDH2 PDC1 -0.19 -0.05 0.10 -0.07 -0.27
IDH2 PDC5 0.62 -0.08 0.16 -0.12 0.10
BDH2 CDC19 0.14 -0.45 -0.29 0.41 -0.15
BDH2 ENO2 -0.06 -0.17 -0.31 0.33 -0.24
BDH2 PDC1 -0.05 -0.47 -0.42 0.58 -0.07










































































Figure B.1: Controlled by a certain FDR, the detected number of significant triplets by
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Figure B.2: Jitter plot of the q-values of the enriched gene sets for all the genes from top 500
triplets using the minus log 10 scale. (A) is for GO terms and (B) is for KEGG pathways.
The values larger than 10 are cut off to be 10. The horizontal line is y = − lg(0.05).
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Figure B.3: The number of enriched gene sets for Z genes from different numbers of top
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Figure B.4: Jitter plot of the q-values of the enriched gene sets for the Z genes from top 1000
triplets using the minus log 10 scale. (A) is for GO terms and (B) is for KEGG pathways.



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure B.5: Top 1000 triplets’ test statistics correlation between pairwise single studies and
meta-analysis. Each dot represents a triplet selected by study in the x-axes and its test






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure B.6: Top 1000 triplets’ rank correlation between pairwise single studies and meta-
analysis. Each dot represents a triplet selected by study in the x-axes and its test statistics































































































































































































































































































Figure B.7: Number of overlapped triplets among meta and single analysis for different top
number of significant triplets. (A) is for top 2000 significant triplets; (B) is for top 4000
significant triplets; (C) is for top 6000 significant triplets.









































































































































































Figure B.8: Overlap of meta and single analysis. (A) is for the number of overlapped
enriched GO terms using Z genes from top 1000 triplets are for gene set enrichment analysis;
(B) is for the number of overlapped enriched KEGG pathways using Z genes from top 1000
triplets for gene set enrichment analysis.
139
APPENDIX C
SUPPLEMENTARY MATERIAL FOR AIM 3
C.1 SUPPLEMENTARY TABLES
Table C.1: Parameter setting for synthetic data.
Symbol Setting Note
S 4 Number of studies
K 1 Number of bicluster layers
p 100, 100, 80 and 70 Number of samples for each study
n 500 Number of genes
µ0 0, 0, 0 and 0 Background mean value for each study
σ0 1, 1, 1 and 1 Background SD value for each study, adjusted by simulation
µ 1.5, 1.5, 1.5 and 1.5 Bicluster mean value effect for each study
αmin 0.2, 0.2, 0.2 and 0.2 Bicluster row effect min value for each study
αmax 0.5, 0.5, 0.5 and 0.5 Bicluster row effect max value for each study
βmin 0.2, 0.2, 0.2 and 0.2 Bicluster column effect min value for each study
βmax 0.5, 0.5, 0.5 and 0.5 Bicluster column effect max value for each study
gn1 50 Bicluster consistent gene size, 30 if gn2 or gn3 is non-zero
gn2 0 or 10 Bicluster prevalent gene size
gn3 0 or 10 Bicluster study-specific gene size
sn 40, 30, 25 and 25 Bicluster sample size for each study
140













1 291 260 164 161 533 1981
2 291 260 164 161 533 1981
3 291 260 164 161 533 1981
4 291 260 164 161 533 1981
5 291 260 164 161 533 1981
6 291 260 164 161 533 1981
7 291 260 164 161 533 1981
8 291 260 164 161 533 1981
9 291 104 65 161 112 567
10 291 72 48 54 487 1979
11 291 187 36 32 528 1780
12 291 47 41 69 105 423
13 291 98 114 69 425 784
14 291 175 109 59 215 900
15 291 108 94 52 407 959
Table C.3: Association p-values between bicluster sample splitting and clinical information.
Bicluster METABRIC ER +/- p-value METABRIC survival p-value
9 < 2.2E-16 (ER - enriched) 1.14E-14
10 0.05596 (ER + enriched) 0.371
11 < 2.2E-16 (ER + enriched) 1.36E-3
12 < 2.2E-16 (ER - enriched) 7.13E-11
13 3.02E-15 (ER + enriched) 8.81E-05
14 2.01E-04 (ER + enriched) 3.55E-04
15 < 2.2E-16 (ER - enriched) 7.77E-16
141
Table C.4: Association between breast cancer subtypes and 12th bicluster sample splitting
for METABRIC cohort.
Breast cancer subtype # samples outside the bicluster # samples inside the biclsuter
Luminal A 713 6





Table C.5: Number of significantly enriched pathways for each breast cancer biclusters
(FDR=5%).




GO BP GO CC GO MF
9 0 0 0 37 0 0 0
10 1 24 32 279 285 30 22
11 0 0 0 29 0 0 0
12 1 2 17 239 27 6 3
13 0 4 10 299 210 20 22
14 0 3 9 307 90 28 16

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure C.1: Comparison of seven meta terms performance on (A) consistent + prevalent
gene simulation; (B) consistent + study-specific gene simulation without pruning steps. For
consistent + prevalent gene simulation, truth 1 means only using consistent genes as the
underlying truth, truth 2 means using exactly the consistent genes and prevalent genes
inside each study, and truth 3 means using consistent + prevalent genes as the truth for all
studies. For meta analysis, truth 3 is preferred that both consistent and prevalent genes are
preferred to be detected. For consistent + study-specific gene simulation, truth 1 means only
using consistent genes as the underlying truth, truth 2 means using exactly the consistent
genes and study-specific genes inside each study, and truth 3 means using consistent + study-
specific genes as the truth for all studies. For meta analysis, truth 1 is preferred that only
common genes are preferred but not the study-specific genes.
143
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Figure C.2: Performance of bicluster detection without pruning step (red line), with pruning
step where parameters are selected by gap statistic (green line), and the best performance
within the searching space (blue line) in consistent + prevalent gene simulation. Truth 1
means only using consistent genes as the underlying truth, truth 2 means using exactly the
consistent genes and prevalent genes inside each study, and truth 3 means using consistent
+ prevalent genes as the truth for all studies. For meta analysis, truth 3 is preferred that
both consistent and prevalent genes are preferred to be detected.
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Figure C.3: Performance of bicluster detection without pruning step (red line), with pruning
step where parameters are selected by gap statistic (green line), and the best performance
within the searching space (blue line) in consistent + study-specific gene simulation. Truth
1 means only using consistent genes as the underlying truth, truth 2 means using exactly
the consistent genes and study-specific genes inside each study, and truth 3 means using
consistent + study-specific genes as the truth for all studies. For meta analysis, truth 1 is
preferred that only common genes are preferred but not the study-specific genes.
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Figure C.4: Performance of bicluster detection without pruning step (red line), with prun-
ing step where parameters are selected by log of gap statistic (green line), and the best
performance within the searching space (blue line).
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Figure C.5: Performance of bicluster detection without pruning step (red line), with prun-
ing step where parameters are selected by log of gap statistic (green line), and the best
performance within the searching space (blue line) in consistent + prevalent gene simula-
tion. Truth 1 means only using consistent genes as the underlying truth, truth 2 means
using exactly the consistent genes and prevalent genes inside each study, and truth 3 means
using consistent + prevalent genes as the truth for all studies. For meta analysis, truth 3 is
preferred that both consistent and prevalent genes are preferred to be detected.
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Figure C.6: Performance of bicluster detection without pruning step (red line), with pruning
step where parameters are selected by log of gap statistic (green line), and the best perfor-
mance within the searching space (blue line) in consistent + study-specific gene simulation.
Truth 1 means only using consistent genes as the underlying truth, truth 2 means using
exactly the consistent genes and study-specific genes inside each study, and truth 3 means
using consistent + study-specific genes as the truth for all studies. For meta analysis, truth
































Figure C.7: Performance of bicluster detection with incorrect ( 2% to 6%, red line), correct
(7% to 13%, green line), and without gene size control (blue line). The underlying truth of
gene selection rate is 10%
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Figure C.8: Meta-bicluster detect from 5 breast cancer cohorts. Orange bar: samples inside
the bicluster; grey bar: samples outside the bicluster.
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